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Introduction 
 
INTRODUCTION 
 
Skin, the largest organ in the human body, plays a crucial role in the 
sustenance of life through the regulation of water and electrolyte balance, 
thermoregulation, and by acting as a barrier to external noxious agents 
including microorganisms, however , when the epithelial integrity of skin is 
disrupted, a wound results.
1 
A wound is breach in the skin and the exposure of subcutaneous tissue 
following loss of skin integrity provides a moist, warm and nutritive 
environment that is conducive to microbial colonization and proliferation.
2
 
In developing countries like India, large number of people die daily of 
preventable and curable diseases such as wound infections. 
 Wound infections are one of the most common hospital acquired 
infections and are an important cause of morbidity and account for 70-80% 
mortality.
3,4 
 The importance of wound infections, in both economic and human 
terms, should not be underestimated 
5
. In a study on an average, patients with 
an infected wound stay about 6-10 days more than if the wounds heal without 
infections
6
. 
The wound infection depends on a complex interaction between host 
factors like immunity, nutritional status and age , wound related factors like 
magnitude of trauma, dead space, devitalization and presence of hematoma 
and microbial factors like toxins, invasion and resistance to antibiotics
7
. 
 Most wound infections can be classified into two major categories, 
skin and soft tissue infections, although they often overlap as a consequence 
of disease progression
8
. 
           Exogenous wound infection  include those associated with traumatic 
injury or decubitus pressure ulcer, animal or human bites, burns or foreign 
bodies in skin or mucous membrane.  
Endogenous wounds and abscess may be associated with appendicitis, 
cholecystitis, cellulitis, dental infection, septic arthritis, osteomyelitis, 
empyema, sinusitis. Most of these processes are nosocomial contracted after   
invasive procedures, surgical manipulation, placement of prosthesis. Others 
derived from hematogenous spread from primary site of infection
9
. 
 The potential wound pathogens are Gram positive cocci 
(Staphylococcus aureus, Streptococcus species, Coagulase negative 
Staphylococcus , Enterococcus species), Gram negative bacilli(Escherichia 
coli, Pseudomonas aeruginosa , Klebsiella pneumoniae, Proteus species, 
Enterobacter species), anaerobes(Bacteroides, Clostridial species)
10  
.Wound 
infections are mostly due to nosocomial pathogens that differ from country to 
country and from hospital to another within the same region
11
, which remains 
the major source of postoperative morbidity
12
. 
 Wound infection by resistant bacteria worsens the condition
13
. Rapid 
spread of resistant microbes affected the effectiveness of antimicrobials 
creating worldwide  problem
11
. The condition is serious in developing 
countries owing to irrational prescription of antimicrobial agents
14
. The battle 
between bacteria and their susceptibility to drugs is yet problematic among 
public, researchers, clinicians, and drug companies looking for effective 
drugs. Measures to control problem include development of new 
antimicrobial, better infection control program and more appropriate use of 
existing antimicrobial agents
15,16,17
.Many researchers made different 
recommendations on the susceptibility of microorganisms to drugs
18
. 
 This study aims to find out common bacterial isolate   and their 
antibiotic resistance pattern, the incidence of ESBL producers and MRSA in 
wound infections.   
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Review of Literature  
 REVIEW OF LITERATURE 
Background: 
 Hippocrates  ( Greek physician and surgeon, 460-377 BC )  known as 
father of medicine, used vinegar to irrigate open wounds and wrapped 
dressings around wounds to prevent further injury. Galen  (Roman 
gladiatorial surgeon,130AD)  was first to recognize that pus from wounds 
inflicted by the gladiators heralded healing (pus bonum et laudabile). 
Unfortunately this observation was misinterpreted and the concept of pus 
preempting wound healing preserved well into the eighteenth  century. The 
link between pus formation and healing was  emphasised  so strongly that 
foreign material was introduced into wounds to promote pus formation. The 
concept of wound healing remained a mystery, as highlighted by the famous 
saying by Ambrose Pare (French military surgeon, 1510-1590 AD) “I dressed 
the wound god healed it”. 
 The scale of wound infections was most evident in times of war. 
During the American civil war, erysipelas and tetanus accounted for 17,000 
deaths, according to an anonymous source in 1883. 
 Because compound fractures at that time almost invariably were 
associated with infection, amputation was the only option, despite a 25-90% 
risk amputation stump infection. 
 Koch (Professor of Hygiene and Microbiology, Berlin, 1843-1910) 
first recognized the cause of infective foci as secondary to microbial growth 
in his nineteenth century postulates. Semmelweis (Austrian Obstetrician, 
1818-1865) demonstrated a 5 fold decrease in puerperal sepsis by hand 
washing between performing postmortem examinations and entering the 
delivery room. Joseph Lister (Professor of Surgery, London, 1827-1912) and 
Louis Pasteur (French Bacteriologist, 1882-1895) revolutinised the entire 
concept of wound infection. Lister recognized that antisepsis could prevent 
infection. In 1867, Lister placed carbolic acid into open fractures to sterilize 
the wound and to prevent sepsis and hence the need for amputation. In 1871, 
Lister began to use carbolic spray in the operating room to reduce 
contamination. However, the concept of wound suppuration persevered even 
among eminent surgeons, such as John Hunter( 1728-1793.) 
 World War I resulted in new types of wounds from high velocity bullet 
and shrapnel injuries coupled with contamination by the mud from the 
trenches. Antoine Depage (Belgian military Surgeon,(1865-1925) 
reintroduced wound debridement and delayed wound closure and relied on 
microbiological assessment of wound brushings as guidance for the timing of 
secondary wound closure. Alexander Fleming (Microbiologist, London, 
1881-1955) performed many of his bacteriological studies during World War 
I and is credited with discovery of penicillin. 
 As late as nineteenth century, aseptic surgery was not routine practice. 
Sterilization of instruments began in the 1880 as did the wearing of gowns, 
masks and gloves. Halsted (Professor of Surgery, John Hopkins university, 
United States, 1852-1922) introduced rubber gloves to his scrub nurse 
because she was developing skin irritation from the chemicals used to 
disinfect instruments. The routine use of gloves was introduced by Halsteds 
student J.Bloodgood. 
 Penicillin was first  used clinically in 1940 by Howard Florey. With the 
use of antibiotics, a new era in the management of wound infections 
commenced.  
 
WOUND MICROBIOLOGY : 
Microbial Colonization: 
Exposed subcutaneous tissue provides a favourable substratum for a wide 
variety of microorganism  to contaminate and colonize, and if the involved 
tissue is devitalized (Eg. Ischemic, hypoxic or necrotic) and the host immune 
response is compromised, the conditions become optimal for microbial 
growth. 
 
 Wound contaminants are likely to originate from three main sources ; 
1. The environment (exogenous) microorganism in the air or those 
introduced by traumatic injury, 
2. The surrounding skin (involving members of the normal skin flora 
such as Staphylococcus epidermidis, Micrococci, Skin Diptheroids and 
Propionibacteria).     
3. Endogenous sources involving mucous membranes (primarily the 
Gastrointestinal, Oropharyngeal and Genitourinary mucosa)
23  
the 
normal microflora of the gut, the oral cavity, and the vagina are both 
diverse and abundant and these sources (particularly the oral and 
gastrointestinal mucosa) supply the vast majority of microorganisms 
that colonize wounds. 
  Whereas a minor, healing wound may allow sufficient time for only 
relatively small number of skin contaminants to take residence, the continued 
exposure of devitalized tissue associated with a slowly healing chronic 
wound is likely to facilitate the colonization and establishment of a wide 
variety of endogenous microorganisms.  Dental plague, the gingival crevice, 
and the contents of the colon contain approximately 10
10
 microorganism per 
g of tissue, of which up to 90% of the oral microflora
24
 and upto 99.9% of the 
colonic microflora are anaerobes
25
.   
In view of this situation it is reasonable to predict that wounds with a 
sufficiently hypoxic and reduced environment are susceptible to predict that 
wound with a sufficiently hypoxic and reduced environment are susceptible 
to colonization by a wide variety of endogenous anaerobic bacteria. However 
to date, widespread opinion among wound care practitioners is that aerobic or 
facultative pathogens such as Staphylococcus aureus, Pseudomonas 
aeruginosa and beta haemolytic Streptococci are primary causes of delayed 
healing and infection in both acute and chronic wound.  This was so because 
the isolation of anaerobic bacteria was minimal or omitted, whereas when 
wounds are investigated by appropriate microbiological techniques anaerobes 
are found to form a significant proportion of microbial population in both 
acute and chronic wounds.   
Factors Predisposing to Microbial Proliferation : 
 Surgical wounds will heal rapidly if blood perfusion is maximized, 
thus delivering O2, nutrients and cells of the immune systems to the site of 
injury and providing minimal opportunity for micro organism to colonize and 
proliferate
26
 . In contrast, chronic, non healing wounds are frequently hypoxic 
as a consequence of poor blood perfusion (ischemia), and host and microbial 
cell metabolism contributes further to a lowering of the local PO2. Thus, cell 
death and tissue necrosis caused by tissue hypoxia or anoxia are likely to 
create ideal growth condition for members of wound microflora, including 
fastidious anaerobes that will proliferate as residual O2 is consumed by 
facultative bacteria.   
 As well as being essential for cell growth and wound  healing,  O2 is a 
critical component of the respiratory burst activity in polymorphonuclear 
leukocytes resulting in the intracellular production of highly potent 
antimicrobial metabolites.  A Significant reduction in the killing capacity of 
polymorphonuclear leukocytes at a PO2 of < 30 mmHg has been reported
27
 
and in this respect, poorly perused wound tissue is considered to be far more 
susceptible to infection than are wounds involving well perfused  tissue.
28 
Wound infection : 
 Infection occurs when virulence factors expressed by one or more 
micro- organisms in a wound  compete the host natural immune systems and 
subsequent invasion and dissemination of microorganism in viable tissue 
provokes a series of local and systemic host responses. Characteristic local 
responses are a purulent discharge or painful spreading erythema indicative 
of cellulites around a wound
29
.  
 The progression of a wound to an infect state is likely to involve a  
multitude of microbial and host factors, including the type, site and depth of 
the wound, the extent of nonviable exogenous contamination, the level of 
blood perfusion to the wound, the microbial load combined level of virulence 
expressed by the types of micro organism involved.  Most acute and chronic 
wound infections involve mixed populations of both aerobic and anaerobic 
micro organisms. 
 An acute wound usually occurs in a normal, healthy person and is 
either closed primarily or allowed to close by secondary intention. Most 
injuries to whole organs or tissues can be considered acute wounds. 
Surgical Wound infections: 
Definition : Clinically a surgical site is considered to be infected when there 
is purulent discharge from the incision site 
30,31
. According to Centre for 
disease control (CDC) definition surgical site infection (SSI) is diagnosed on 
the basis of one of the following.
32
 
a)   Purulent discharge from a incision site a drain 
b)   Positive results obtained from culture of fluid obtained from a surgical                        
site closed primarily. 
c)   Surgeons or attending physician’s diagnosis of infection. 
d)   Surgical site which requires reopening. 
 Bacteria account for majority of SSI  Staphylococcus aureus, 
Staphylococcus epidermidis and enteric Gram negative bacteria are common 
in clean surgeries. When  surgery involves the gastrointestinal, respiratory or 
genitourinary tract the pathogens  are polymicrobial involving aerobic and 
anaerobic organisms. 
 D.C. Berridge  et al and Bengt Gastrin et al 
33,34
 their studies on 
Orthopaedic surgeries found Staphylococcus aureus and Staphylococcus 
epidermidis to be the common isolates.  Enterobacteriaceae, Enterococci, 
Streptococcal species, Bacteriodes and Pseudomonas were the other isolates.
 Studies involving a large number of generalized wound types have  
reported overall infection rates of 3.4% in 5129 operations,
35
 4.7% in 62939 
operations 
36
and 9.4% in 1,770 operations
. 37
 In the last two studies, the 
infection rates ranged from 1.5% and 5.9% following clean surgery to 40% 
and 52.9% following contaminated surgery.  
 Minimizing the incidence of postoperative wound infection relies on 
adequate sepsis and antisepsis and preservation of the local host defenses.
38
  
Asepsis involves the utilization of effective infection control procedures (eg. 
air filtration, skin barrier garments, disinfection) to minimize exogenous 
microbial contamination during surgery.   Antisepsis involves the use of skin 
antiseptics on the operative site and also in the case of dirty surgical 
procedures, administration of prophylactic antibiotics at a time point just 
prior to surgery that will ensure adequate tissue levels of antibiotic during 
surgery.  
 As part of the surgical procedure, the endogenous and exogenous 
microbial contamination must be minimized by ensuring good aseptic, skilled 
surgical techniques and minimizing the duration of surgery, while also 
optimizing the local wound conditions.
39
. This primarily involves removing 
any devitalized  tissue to re establish blood flow to the wound area thereby 
maintaining adequate perfusion to enable the delivery of immune cells, 
oxygen and nutrients and reducing the microbial load. 
Acute soft tissue infections: 
 Acute soft tissue infections include cutaneous abscesses, traumatic 
wounds and necrotizing infection. In a cataloging of the bacteriology of a 
large number of cutaneous abscesses (with unspecified individual 
predisposing causes), Staphylococcus aureus was the single most common 
aerobic facultative isolate followed in frequency by streptococci, both 
groupable (A,B,C,D) and non groupable.
40
 Among anaerobic isolates 
Bacteroides species (most commonly Bacteroides fragilis group) were most 
frequent followed by Peptostreptococcus species and Clostridium species.  
These abscesses are commonly polymicrobial (mixed aerobic and anaerobic). 
As might be predicted Staphylococcus is the principle isolate in infections 
(both abscesses and wounds) of the extremities and trunk, whereas anaerobes 
are more numerous than aerobic facultative species in such infections In the 
genital, perirectal, inguinal, and head and neck areas. 
 In two studies microbiological investigations have shown that 
Staphylococcus aureus is the single causative bacterium in approximately 25 
to 30% of cutaneous abscesses 
41,42
.  Staphylococcus  aureus has also been 
recognized as being the most frequent isolate in superficial infections seen in 
hospital accident and emergency departments.  However other studies have 
demonstrated that approximately 30 to 50% of cutaneous abscesses 
41,40
 ,50% 
of traumatic injuries of varied etiology
43,44
 and 47% of necrotizing soft tissue 
infection
45
 have a polymicrobial aerobic and anaerobic microflora.  
Necrotizing soft tissue infection, they involve the skin, (Eg. Clostridial and 
Non Clostridial anaerobic cellulitis) subcutaneous tissue to the muscle fascia 
(necrotizing fasciitis) and muscle tissue (Streptococcal myositis and 
Clostridial myonecrosis). 
Cellulitis: 
 Cellulitis is an acute, spreading infection of the skin that extends 
deeper and involves the subcutaneous tissues. Group A Streptococcal or 
Staphylococcal aureus is the most common etiologic agent. Previous trauma 
(laceration, puncture wound) or an underlying skin lesion (furuncle, ulcer) 
predisposes to the development of cellulitis.  Occasionally, Cellulitis results 
from blood- borne spread of infection to the skin and subcutaneous tissues; 
rarely, it is caused by direct spread from subjacent infections (subcutaneous 
abscesses. fistulas from osteomyelitis).  
  Cellulitis is a serious disease because of the propensity of infection to 
spread (via )lymphatics and blood stream.  Cellulitis of the lower extremities 
in older patients may be complicated by thrombophlebitis.  A 
polymorphonuclear  leukocytosis is usually present regardless of the bacterial 
etiology.  Data from studies employing culture of needle aspirates from areas 
of cellulitis have provided the best information on the most likely 
pathogens.
46,47
  
 A pathogen was identified in 30% of 284 patients gram positive 
bacteria (mainly Staphylococcus aureus, group A Streptococci, group B 
Streptococci, viridans Streptococci, and Enterococcus faecalis) represented 
79%, the reminder were Gram negative bacteria (Enterobacteriacea, 
Hemophilus influenza,  Pastuerella multocida,  Pseudomonas aeruginosa and 
Acinetobacter species).   
 A broader spectrum of pathogens has been isolated from deep wounds 
or debrided tissue in diabetic patients with limb threatening infections 
including cellulitis). Theses comprised Gram positive aerobes in 56% of 
patients (Staphylococcus aureus,  Enterococcus species and various 
Streptococcal species)Gram negative aerobes in 22% (Enterobacteriaceae, 
Acinetobacter, Pseudomonas aeruginosa) and anaerobes in 22% (Bacteriodes, 
Peptococcus).  In cellulitis complicating decubitus ulcers, this broad range of 
microorganism also be considered as potential pathogens.  If this 
complication develops in a hospitalized patient, resistant nosocomial 
pathogens should be considered when deciding on empirical antibiotic 
coverage. 
Chronic wounds : 
 Chronic wounds remain one of the most costly unsolved problem in 
health care today.  Leg ulcers, pressure ulcers, ischemic ulcers and diabetic 
foot ulcers are examples of commonly encountered chronic wound infections. 
 Four basic condition exist in open wounds resulting from the level of 
bioburden present (bacterial contamination normal but short lived state, 
colonization-normal state, critical colonization -abnormal state and infection - 
abnormal state).  The two abnormal states have the potential to disrupt the 
orderly healing sequence, which result in the development of a chronic 
wound. 
 Many wounds healing by secondary intention become indolent. 
Extending periods of patient discomfort and inconvenience and increasing 
health care costs and staff overload. Although wound cease to heal for many 
reasons, perhaps the most common emanates from the effects of wound 
bioburden, due  to invasive infection, the  quantity of colonizing microbes, 
the mixture of species in the wound base, or effect of their toxins, in addition, 
the impact of the wounds anatomical position,  shape or presentation, the 
patients level of health and control of underlying pathologies, presence of 
infection and potentiating factors such as foreign bodies, hematoma, and 
necrotic tissue, all require consideration.
 
 Open wound pathogens are commonly considered to be aerobic, 
(Essentially Staphylococci and Streptococci species) But anaerobic species 
(Peptostreptococcus, Prevotella, Porphyromonas and Bacteroides) are also 
now thought to have a role to play because the frequency of their isolation 
increases in clinically infected chronic wounds.  They may act synergistically 
to invade the tissue even if they themselves do not penetrate far into the deep 
wound compartment.
48
 Recent in vitro research 
49
shows how anaerobic 
species cause healing delay by inhibiting fibroblast and keratinocyte 
proliferation, keratinocyte wound repopulation and endothelial tubule 
formation. 
 A third group of organisms, Gram negative bacteria (eg. Pseudomonas 
aeruginosa, Escherichia coli, Klebsiella, Proteus, Acinetobacter and 
Enterobacter species) tend to appear in the open wound at approximately 4 
week from intiation. This group generally does not penetrate, but adds to the 
large members of organisms in the wound bioburden.  Gram negative 
bacteria possess antiphagocytic and adherence mechanisms, endotoxins and 
some exotoxins making them difficult to remove and kill and allowing the 
toxins to prolong the inflammatory response into a chronic disordered 
process.  
 Pseudomona
,
s exotoxin pyocyanin can cause wound extension without 
cellulitis.  At a certain quantity , these organisms may start quorum sensing or 
communicating chemically and turn on expression of virulence factors and 
the production of biofilm causing a great deal of fuss and bother but no 
classic cellulitic infection in the open wound. Hence chronic infected wounds 
are polymicrobial and of mixed aerobe/anaerobe populations  making it 
impossible to designate the pathogens, Although competition through 
cohabitation on intact skin appears to decrease the virulence of an individual 
species.  The polymicrobial natural of the open wound is likely to provide 
opportunities for synergism, producing infection or delayed healing. 
 Another consideration is the effect of specific species on the wound.  
Beta hemolytic Streptococci, notably (Streptococcus pyogenes), are 
pathogenic at numbers that are significantly lower than many other species.  
Other species (Eg .Streptococcus aureus, Proteus and Escherichia coli) may 
have a positive effect by provoking  a  inflammatory response, accelerating 
wound repair by stimulating blood flow 
50.51
.  Increased angiogenesis 
produced by a low bioburden has a positive effect, but uncontrolled 
angiogenesis is linked to excessive scar formation. 
 The acceleration stimulus also may be paralleled by an increased 
strength in the wound because of increased collagen production.  On the other 
hand, the outcome of high bioburden is often decreased strength.   
 Trengrove et al
52
 support the notion that the presence of multiple 
species (four or more) delays healing. In general fewer species and numbers 
are better for normal healing progress. 
 A diagnosis of critical colonization is made from two main signs; 
cessation/delay in healing (despite receiving what would normally be 
considered effective therapy) and the absence of cellulitis.  In addition, 
corroborative signs include a wet rather than moist wound, abnormal smell, 
change in exudates color, dull dark red or overly bright red discoloration of 
granulation, a edematous wound base that does not have a granular 
appearance. 
Diabetic foot ulcer infections :  
 Diabetic  patients have always suffer  from foot ulceration. This 
complication has become more prevalent since advances in the general 
medical care of diabetes, particularly the discovery of insulin, have prolonged 
the life expectancy of patients with this disease.   
 Despite progress in the treatment of ulcers, prevention and achieving 
healing of established ulcers remains a considerable challenge.  With 
enthusiasm and the application of basic principles, however much can be 
achieved in treating patient with this common complication of diabetes. It is 
first important to appreciate that the etiology of diabetic foot disease is truly 
multifactorial.  Within any individual patient, one factor may predominate 
over all or some of the others, but generally foot disease arises from more 
than one cause.   
 Factors to consider include neuropathy, macrovascular and 
microvascuar disease, infection, connective tissue abnormalities and 
hematological disturbances. Identification of the dominant causative factors 
in each case is essential in planning treatment and the concept of the 
neuropathic foot, the neuroischaemic foot and the ischemic foot is very 
useful.  
 S.Fredenburg stated that altered immune response, peripheral vascular 
disease and neuropathy are key factors in the production of infection.
53
  
Joseph W.S. also stated that three main factors are responsible for the 
diabetic foot infections.  (Neuro, angio and immunopathy) 
54
, Wheat., L.J. et 
al stated that successful treatment of diabetic foot infection requires accurate 
assessment of the extent and etiology of infections and often involves broad 
antibiotic coverage and surgery.
55
 
  The infection is virtually always polymicrobial with Gram 
positive and negative aerobes and anaerobes.
55,56,57,58
,  (Staphylococcus 
aureus, Bacteroides, Proteus, Enterococcus, Clostridia and Escherichia Coli  
being present. Lipksy, B.A. et al described that aerobic Gram positive cocci 
are the major pathogens in the diabetic foot infections. Aerobic Gram 
negative bacilli or anaerobes are present in chronic or previously treated 
infections.
59
 
 Staphylococcus aureus was the commonest bacterial species isolated 
while anaerobic bacteria comprised only 10% of the isolates in a study done 
by Jones E.W. 
60
Anaerobes are occasionally isolated in the osteomyelitis of 
the foot in diabetic foot infections
. 59
 Armstrong DG et al reviewed that 
anaerobic species were isolated in only 5% of all cultures.
61 
 Antibiotic treatment can be valuable when infection is local or 
superficial. The choice of drug should take account of the polymicrobial 
nature of these lesions.  There is some evidence that prolonged antibiotic 
treatment for small ulcers result in a more favourable  outcome, although 
there is some debate on this issue.  Once there is tissue destruction secondary 
to infection surgical  debridement is required, although broad spectrum 
antibiotics still have an important role to play. 
 Bamberger, D,M.et al reviewed that diabetic foot infection in absence 
of extensive necrosis or gangrene usually responds to antimicrobial therapy 
without the need for an ablative surgical procedure.
62
  Peterson L.R. et al 
suggested that ciprofloxacin offers promise for the improved outcome of 
patient with the serious infected diabetic foot infections.
63
 
 Conservative treatment including culture guided parenteral and oral 
antibiotics is successful without amputation in a large proportion of diabetic 
patients admitted for foot  ulcers.
56, 64
 However, with optimal treatment 
involving debridement of devitalized tissue, the use of appropriate dressings 
and pressure relief wound infection can be minimized. Boultonj et al 
65
reported an infection rate of 2.5% in diabetic wounds treated with a 
moisture  retentive hydrocolloid dressing, compared with a 6% infection rate 
under a traditional gauze dressing. Laing 
66
 also observed a similar infection 
rate (2%) in diabetic foot ulcers treated wit a hydro colloid dressing, despite 
the number of species increasing during treatment.  
 As bactericidal activity of neutrophils is impaired in diabetic, G-CSF 
which increase the release of neutrophils from the bone morrow and 
improves neutrophil function is assessed as adjuvant therapy for the treatment 
of severe diabetic foot infections.
67
 
 Other adjunctive therapy using hyperbaric oxygen and topical growth 
factors can be helpful in treating diabetic foot infections.
68
Self foot care 
behavior , as well as foot care given by health care providers reduced the 
prevalence of lower extremity clinical disease in patients with diabetes. 
 WOUND – SAMPLING METHODS : 
Wound tissue sampling : 
 The acquisition of deep tissue during biopsy following initial 
debridement and cleansing of superficial debris is recognised as being the 
most useful method for determining the microbial load and the presence of 
invasive pathogens 
69
.  Another technique involving dermabrasion has  
recently been described that enables the acquisition of deeper tissue without 
being as invasive as the biopsy method.
70 
Wound fluid sampling : 
 When a copious volume of wound fluid exists, sampling by needle 
aspiration can be employed.  This is the most useful procedure for sampling 
purulent fluid from intact cutaneous abscesses. In cavity wounds such as 
some pressure sores, irrigation with sterile saline and gentle massaging may 
be performed to provide fluid for aspiration. 
Wound swabbing:  
 Most frequently involves the use of a cotton tipped swab to sample 
superficial wound fluid and tissue debris, and this enables a semiquantitative 
and qualitative analysis of the wound microflora.  Johnson et al 
71
 
demonstrated superior isolation of anaerobic bacteria from infected diabetic 
foot ulcers by a swab technique than by a needle aspiration technique.  
Studies by Bowler and Davies.
48
 have demonstrated the efficacy of the swab 
sample in isolating anaerobes from a various acute and chronic wounds. 
Specimen Transport : 
 Following the acquisition of wound fluid or tissue for microbiological 
analysis, prompt delivery of the specimen to the laboratory is considered to 
be of utmost importance particularly if anaerobic bacteria are being 
investigated.  Aspirates of purulent fluid and tissue samples are considered to 
be preferred to swabs
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 because they will maintain the condition required to 
sustain microbial viability (a moist and reduced environment) if processed 
promptly.  
 However pre reduced commercially available transport media offer 
advantages if specimen culture is delayed beyond 1-2 hours after isolation.  
For specimens that cannot be transferred to the laboratory within 12 hours, 
storage at room temperature if considered to be appropriate for the 
maintenance of aerobic and anaerobic microorganisms; elevated temperatures  
may cause differential growth or death of some microorganisms, and lower 
temperatures will cause increased O2 diffusion. 
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Analysis of wound specimen : 
 Information regarding the type of wound (Eg. surgical, traumatic, leg 
ulcer or pressure ulcer) position of the wound, clinical signs of infection, 
presence of necrosis, associated malodor, and antimicrobial therapy will 
greatly assist the microbiologist in predicting the microorganisms that are 
most likely to be involved and therefore the types of culture media and 
complementary analyses that should be used.  Also, the provision of 
information regarding current antibiotic treatment may assist the 
microbiologist in determining which microorganisms are most likely to 
persist in a wound and therefore guide appropriate culturing procedures.  
Since microbial culture and antibiotic sensitivity result cannot be generated in 
less than 48h (and may, on occasion, take considerably longer), a number of 
rapid investigations must be considered at the outset. 
Gram Stain:  
 Despite being used for over a century Gram’s stain is still the most 
important stain in microbiology 
74 
and is widely used as a rapid technique for 
guiding antibiotic therapy in life threatening infections such as bacterial 
meningitis,  in wound management, Gram staining of a known volume of 
tissue biopsy specimen homogenate has been used to rapidly estimate the 
microbial load of a wound and thus facilitate successful closure of surgical 
wounds.
75
 However in diabetic foot infection and burn wounds, both of 
which involve complex microbial ecosystems a poor correlation between 
Gram stain and culture results from deep tissue biopsy specimens has been 
reported. 
 Meislin et al 
42
 reported that the Gram stain reliably indicates sterile 
and mixed abscesses, as well as those containing pure Straphylococcus 
aureus.  Similarly, this procedure may also facilitate identification of the 
etiological agent of wound infection following clean surgery, where there is a 
higher probability of one microorganism being involved (Eg. Clusters of 
Gram positive cocci) in most other wound types that are characterized by 
complex aerobic-anaerobic micro flora, the Gram stain has little value, 
although the combined presence of leucocytes and bacteria is likely to be a 
good indicator of infection.  With the exception of Gram positive spore 
forming anaerobes such as Clostridium perfringens, differentiation between 
aerobic and anaerobic bacteria is difficult and is further complicated by the 
fact that many Gram positive anaerobes become Gram variable on exposure 
to oxygen.
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Culture of wound specimen and Antibiogram: 
 Routine analysis of wound specimen normally involves the use of 
selective and non selective agar media to culture aerobic bacteria  and yeasts 
and if a specimen is purulent and or malodorous, anaerobic bacteria also.  
Although anaerobic bacteria often constitute a significant proportion of the 
total micro flora in wounds, their culture and isolation is prolonged and more 
resource demanding than investigation of aerobic bacteria, and consequently, 
anaerobic microbiology is often excluded from a routine analysis. 
 Following incubation under aerobic or anaerobic conditions for 24 to 
48 hours, qualitative and semi quantitative assessments of the cultures are 
normally made.  With the exception of Clostridium species anaerobes (if 
investigated) are likely to be reported as being mixed with aerobic 
microflora. Antibiograms are most frequently performed for the aerobic 
pathogens, particularly if they are cultured in abundance and with minimal 
cohabiting microflora. If aerobes are absent, but the wound is reported as 
being clinically infected, anaerobes should be suspected and investigated 
more thoroughly. 
EXTENDED SPECTRUM BETA LACTAMASES:  
 In recent years there has been an increased incidence and prevalence of 
ESBL (Amber’s class A penicillinases) that hydrolyze and cause resistance to 
oxyamino cephalosporins (extended spectrum cephalosporins) and 
aztreonam.
77,78
  ESBLs are now found in a significant percentage of 
Escherichia coli and Klebsiella pneumoniae strains.  They have also been 
found in Pseudomonas aeruginosa and other Enterobacteriaceae strains like 
Enterobacter, Citrobacter, Proteus, Morganello morganii, Serratia 
marsescens, Shigella dysenteriae.
79
  
 Production of these enzymes is either chromosomally mediated or 
plasmid mediated, Pointed amino acid substitution of the classical plasmid 
mediated beta lactamases like TEM-1 TEM-2 and SHV-1 increase the 
spectrum of activity from earlier generation beta lactams to 3
rd
 generation 
cephalosporins and monobactams. However, they retain their stability against 
cephamycins and carbapenems and are inhibited to an extent by beta 
lactamase inhibitors (clavulanic acid, sulbactam and tazo bactam).  Today 
over 575 different ESBLs have been described.
80
 Being plasmid mediated 
these enzymes spread fast among various bacteria and are important by 
infection control, clinical and therapeutic implication. 
DETECTION METHODS: 
81  
Double disk synergy test:  
 A disk diffusion test in which synergy between third generation 
cephalosporin (3GC) and clavulanate is detected by placing a disk of 
amoxicillin/clavulanate 20µg/10µg) and a disk of third generation 
cephalosporin (3GC) (30µg), 15mm apart (centre to centre) on an inoculated 
agar plate.  A clear extension of the edge of the 3 GC inhibition zone toward 
the disk containing clavulanate is interpreted as synergy, indicating the 
presence of the ESBL. 
 (CLSI) RECOMMENDED METHODS FOR ESBL DETECTION : 
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1.Screening for ESBL producers  
i) Disk diffusion method  
 The CLSI has proposed disk diffusion methods for screening for ESBL 
using disk diffusion methods for antibiotic susceptibility testing and screen 
for ESBL production by noting specific on diameters, which indicate a high 
level of suspicion for ESBL production cefpodoxime, ceftazidime, 
aztreonam, cefotaxime or ceftriaxone was used. 
 A zone inhibition diameter lower than the following values should be 
investigated with confirmatory tests, ceftazidime (<22mm), cefotaxime and 
aztreonam (<27mm) and cerftriaxone(<25mm).  In the case of cefpodoxime, 
the cut off for Proteus mirabilis was (<22mm), whereas in the remaining 3 
species E.coli, Klebsiella pneumoniae, Klebsiella oxytoca was (< 17mm) 
Criteria for screening for ESBL production in other Enterobacteriaceae have 
not been established by the CLSI. 
Broth dilution method : 
 This method can also be used for screening for ESBL producers. It is 
recommended that Escherichia coli, Klebsiella pneumoniae and Klebsiella 
oxytoca strains with Minimum inhibitory concentration (MIC<2 µg/m1) 
against cefotaxime, ceftazidime, cefriaxone or aztreonam and MIC <8µg/m1 
for cefpodoxime should be investigated using specific phenotypic 
confirmatory tests for ESBL production.  For Proteus mirabilis isolates 
confirmatory tests should be performed if strains demonstrate MIC >2µg/m1 
for cefotaxime, ceftazidime or cefpodoxime. 
 
PHENOTYPIC CONFIRMATORY TESTS FOR ESBL 
PRODUCTION:  
(a) Cephalosporin/Clavulanate combination disks: 
 The  CLSI advocates the use of cefotaxime 30µg or ceftazidime disks 
(30 µg) with and without clavulanate (10 µg) for phenotypic confirmation of 
the presence of ESBL .  The disk tests are to be performed with confluent 
growth on Mueller Hinton agar. A difference of 5mm between the zone 
diameters of either of the cephalosporin disks and their respective 
cephalosporin / clavunate disk is taken to be phenotypic confirmation of 
ESBL production. 
b) Broth microdilution:   
 Phenotypic confirmatory testing can also be performed by broth 
microdilution assays using ceftazidime (0.25 to 128 µg/ml), ceftazidime plus 
clavulanic acid (0.25 to 128 µg/ml), cefotaxime (0.25 to 64 µg/ml), and 
cefotaxime plus clavulanic acid (0.25/4 to 64/4 µg/ml). A  twofold serial 
dilution decrease in MIC of either cephalosporin in the presence of clavulanic 
acid was compared to its MIC when tested alone. 
Implications of positive phenotypic confirmatory tests: 
 According to CLSI guidelines, isolates which have positive phenotypic 
confirmatory test should be reported as resistant to all cephalosporins (except 
the cephamycins, cefoxitin and cefotetan) and aztreonam, regardless of the 
MIC of that particular cephalosporin. 
Reporting of microbiological results:    
 The abrupt onset and rapid progression of acute wound infection such 
as necrotizing fascitis usually requires therapeutic intervention (in terms of 
surgical debridement and empiric antibiotic therapy) long before the 
microbiology laboratory can generate result, and consequently the role of the 
laboratory in this situation is limited. 
82
 In contrast, the laboratory has a key 
role to play in providing information about the wounds that are slowly 
deteriorating or failing to heal.   
 From a microbiological perspective, the main pathogen or group of 
microorganisms that the microbiology laboratory should routinely detect and 
report (with antibiograms being provided when appropriate) are as follows, 
Staphylococcus aureus, Pseudomonas aeruginosa, beta haemolytic 
Streptococci, Coliform bacteria, pigmented Gram negative anaerobes 
(Prevotella and Porphyromonas species), non pigmented Gram negative 
anaerobes (primarily Bacteroides,. Prevotellam and Fusobacterium species), 
Peptostreptococcus species and Clostridium species. 
 In order that the microbiology laboratory can provide the wound care 
practitioners with clinically relevant information, it is essential that the 
microbiology results (Eg. Gram stain, culture and antibiogram ) be 
interpreted in  association with clinical information provided by the 
practitioner (Eg. wound type, location, condition, signs of infection and 
sampling method). 
Control of microbial populations in wounds: 
 The reporting by the microbiology laboratory of specific 
microorganisms isolated from a wound and the associated antibiogram  may 
be interpreted by the practitioner as a diagnosis of wound infection that 
requires antimicrobial treatment.  However, with clinical signs of infection 
and careful consideration, a wound should not be treated with systemic 
antibiotics, and it is for this reason that all clinical observation and 
microbiological findings should be taken into consideration before that 
medical microbiologist provides an expert opinion. 
 Although systemic antibiotic therapy is essential for advancing 
cutaneous infections and those that involve deeper tissues, wound that exhibit 
only localized signs of infection or are failing to heal but not to  have clinical 
signs of infection ( heavy colonization) may initially be treated with topical 
agents. Topical antimicrobial agents include both antiseptics and antibiotics 
and the wide choice available creates a further problem to wound care 
practitioner. Other treatment options such as hyperbaric oxygen therapy, 
which facilitates the host immune response and may also have a direct 
antimicrobial effect against some anaerobic bacteria (Eg. Clostridium 
perfringens) antimicrobial peptides, and botanical extracts may also have 
roles to play in wound management and are worthy of consideration. 
 Infected and non infected, non healing wounds can also benefits 
considerably form surgical debridement, since devitalized tissue both 
obstructs the healing process and often forms the focus for microbial 
proliferation. As a consequence,   surgical debridement  will significantly 
reduce the microbial load as well as exposing healthy tissue required for 
wound healing. 
 
 
 
  
 
 
 
 
 
 
 
Aim and Objectives 
 
AIM AND OBJECTIVES 
 
1. To isolate and identify the organism causing wound infections. 
 
2. To detect the antimicrobial susceptibility pattern of the bacterial isolates. 
 
3. To find out the incidence of Methicillin Resistant Staphylococcus aureus. 
 
4. To find out the incidence of Extended Spectrum Beta Lactamase  
producers among Enterobacteriaceae isolates. 
 
4. To select appropriate antibiotic for effective treatment. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Materials and Methods 
 
MATERIAL AND METHODS 
 
Study population: 
 A total of 289   patients with wound infection attending as outpatient 
and inpatient  in  Kilpauk Medical College  and Hospital ,Chennai were 
included in the study. 
Study period: 
March 2009 to February 2010 
 
MATERIALS AND MEHTODOLOGY : 
 Clinical samples like pus, tissue material and discharge from the 
incised lesions or ulcers were analyzed for bacteriological profile and 
antimicrobial susceptibility pattern. Staphylococcus aureus strains were 
analyzed for MRSA and Enterobacteriaceae isolates obtained were analyzed 
for ESBL production. 
The methodology included, 
1. Collection of specimen 
2. Specimen processing 
3. Identification of pathogens 
4. Antimicrobial susceptibility testing 
5. Double disk synergy test for ESBL 
6. Minimum inhibitory concentration 
7. Phenotypic confirmatory test for MRSA 
Collection of specimens: 
1. Pus: 
 The area over the abscess was wiped with sterile saline or 70%alcohol 
and with a sterile syringe and needle, pus was aspirated and collected in a 
sterile test tube. 
2. Swab: 
 The wound was wiped with sterile saline and the swab was rolled 
along the leading edge of the wound and placed in a sterile test tube. Two 
swab specimens were collected, one for smear examination and one for 
culture. 
3. Tissue bits: 
 For chronic wounds, wound area was wiped with sterile saline and 
tissue bits were collected using sterile punch biopsy forceps in a sterile test 
tube containing a small amount of sterile saline to keep the specimen moist. 
 
SPECIMEN PROCESSING: 
 Once the specimen reached the laboratory, smears were prepared by 
smearing the swab or purulent material on a clean glass slide .Tissue 
specimens were ground or minced using sterile scissors and forceps before 
processing. Smears were routinely subjected to Gram staining and examined. 
 The specimens were inoculated onto Blood agar plate, Macconkey agar 
plate and incubated aerobically at 37° c for 18-24 hours. Organisms were 
identified by colony morphology, Gram staining, motility and biochemical 
reactions. 
 Information from the primary plates in   conjunction   with the  
atmospheric  requirements .Grams stain and colonial morphology  of a pure 
isolate provides presumptive identification of anaerobic organisms. 
 
ANTIMICROBIAL SUSCEPTIBILITY TESTING:  
 Routine disk susceptibility testing of the aerobic isolates were 
performed by Kirby  Bauer method in Mueller Hinton agar medium obtained 
from Himedia. 25 ml of prepared medium was poured in to a petridish of 
90mm diameter to obtain a thickness of 4mm.  
 
Preparation of 0.5 Mcfarland’s turbidity standard for inoculum 
preparation: 
 0.05 ml of 1% Barium chloride solution was added to 9.95 ml of 1% 
Sulphuric acid in a test tube with constant stirring to maintain a uniform 
suspension. The Barium sulphate suspension was transferred in  4-6 ml to a 
screw capped tube of same size as those used in growing or diluting the 
bacterial inoculum. The tube was tightly sealed and stored in refrigerator. 
Before each use it was shaken vigorously until all the deposit was raised into 
uniform suspension. 
Preparation of inoculum and inoculation:
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  Morphologically similar colonies from an agar medium was touched 
with a wire loop and the growth transferred to a test tube containing 1.5ml of 
Nutrient broth. The tube was incubated at 35°c until it  is matched in density 
with 0.5 Mcfarland’s standard which corresponds to 150 million organism 
per ml. 
 Within 15 minutes of preparation of the suspension, a sterile cotton 
wool swab was dipped into the suspension and surplus removed by rotation 
of the swab against the side of the tube above the fluid level. The medium 
was inoculated by even streaking of the swab over the entire dried surface of 
the MHA plate 3 times, rotating the plate approximately 60 degrees each 
time. Finally the rim of the agar was swabbed. The lid of the dish was left 
apart for 3 to 5 minutes but not longer than 15 minutes, for the surface of agar 
to dry before placing the antibiotic disks. 
Antibiotic disks:  
 The antimicrobial susceptibility testing for Staphylococcus aureus and 
Coagulase negative Staphylococcus  included Penicillin 10U , Erythromycin 
15 μg, Cotrimoxazole 25 μg, Oxacillin 1 μg, Cefotaxime 30 μg, 
Ciprofloxacin 5 μg, Gentamicin 10 μg, and Amikacin 30 μg disks and 
Vancomycin 30 μg disk used only for Oxacillin resistant strains. 
 For Beta hemolytic Streptococci, the antimicrobial susceptibility 
testing included  Penicillin 10U , Erythromycin 15 μg, Cotrimoxazole 25 μg 
and Cephalexin 30 μg disks. 
 For Enterococci  the antimicrobial susceptibility testing included  
Penicillin 10U , Erythromycin 15 μg,  and Amikacin 30 μg disks. 
 For  Gram negative bacilli the antimicrobial susceptibility testing 
included  Ampicillin 10µg ,  Cotrimoxazole 25 μg, Ciprofloxacin 5 μg, 
Cefotaxime 30 μg, Ceftazidime 30 μg, Gentamicin 10 μg and Amikacin 30 
μg disks and Imipenem disk for ESBL producers. 
 Antibiotic disks were applied with forceps and pressed gently to ensure 
even contact with the medium. The plates were inverted and incubated at 
35°c to 37°c for 16 to 18 hours. Plates were incubated, not stacked more than 
three high.
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Reading zones of inhibition: 
 The diameters of the zones of complete inhibition  were measured, 
including the diameter of the disc. Zones were measured to the nearest whole 
millimeter, using ruler, which was held on the back of the inverted Petri 
plate. The Petri plate was held a few inches above a black nonreflecting 
background and illuminated with reflected light. 
Interpretation: 
 The size of the zones of inhibition were interpreted by referring to the 
NCCLS table -2; volume 20; No. 1; 2000(zone diameter interpretive 
standards) and reported as susceptible, intermediate or resistant to the agents 
that have been tested. 
 
ESBL DETECTION: 
 Enterobacteriaceae isolates with zone of  inhibition diameter <27mm 
for cefotaxime and <22 mm for ceftazidime were further tested for ESBL  
production  by following methods. 
DOUBLE DISK DIFFUSION SYNERGY TEST: 
 In the DDST, synergy was determined between a disk of Augmentin 
(20µg Amoxycillin and 10µg Clavulanic acid)and a 30 µg disk of 3
rd
 
generation Cephalosporin(Ceftazidime) placed at a distance of 15mm apart 
(center to center) on a lawn culture of the resistant isolate under test on MHA 
plate. A clear extension of the edge of the 3
rd
 generation cephalosporin 
inhibition zone toward the disk containing Clavulanate was interpreted as 
synergy indicating the presence of an ESBL.  This extension occurs due to 
the Clavulanate in the Augmentin disk which inactivates the ESBL produced 
by the test organism. 
 
AGAR DILUTION METHOD: 
 Mueller Hinton agar was prepared in flasks and autoclaved. It was then 
allowed to cool in a 50°c water bath. Serial dilution of 3
rd
 generation 
Cephalosporins (Ceftazidime and Cefotaxime) was prepared in sterile 
distilled water to give a final concentration ranging from 2µg to 2048µg/ml. 
After adding the drugs to medium at 50° c, it was  mixed well and poured 
into  sterile Petri dishes. (the media was used immediately otherwise potency 
of drugs will be affected). 
 A control plate containing the test medium without the antibiotic was 
prepared for each series of test. Plates of various concentrations were divided 
into nine quadrants. 0.003ml of inoculums that matched 0.5Mcfarland 
standard was put into the appropriate quadrant and incubated at 37°c for  
16-20 hours. Nine to twelve organisms can be tested using a single plate. 
 MIC noted as the  lowest concentration at which no visible growth 
occurred. Isolates were tested for various concentration of 3
rd
 generation 
Cephalosporins combined with 2µg/ml of Clavulanic acid(0.25µg to 
2048µg/ml of agar) and the MIC was determined. 
 
PHENOTYPIC CONFIRMATORY TEST: 
 Antibiotic sensitivity testing was done on MHA with 0.5Mcfarland 
standard of the organism. The drugs used were Cefotaxime and Ceftazidime 
each 30µg alone and in combination with Clavulanic acid 10µg.Organisms  
with 5mm increase in zone of inhibition with third generation cephalosporin 
and Clavulanic acid were confirmed as   ESBLs .  Quality control strains of 
non ESBL producing organism (Escherichia coli ATCC 25922) and an ESBL 
producing organism (Klebsiella pneumonia ATCC 700603) were used as 
control. 
 
DETECTION OF MRSA STRAINS: 
SCREENING FOR MRSA: Oxacillin disk (1µg) 
Disk diffusion test is performed with  lµg of Oxacillin  disk which  was 
placed on MHA  plate . The zone of inhibition is determined after 24hrs of 
incubation at 37˚C.  The  zone size is interpreted according to CLSI 
guideline. 
Susceptible >13 mm 
Intermediate                                                 11-12mm 
Resistant         < 10 mm 
                                      
 
Cefoxitin disk (30µg) diffusion test: 
The  test was performed with 30 µg of Cefoxitin  disk placed on  
Muller Hinton agar plate without NaCl supplementation. The zone of 
inhibition is determined after 24 hrs of incubation at 37°C. The zone size is 
interpreted according to CLSI guidelines. 
Susceptible >19mm 
Resistant         < 20mm 
 
Quality control used for MRSA detection: 
ATCC Staphylococcus aureus 43300 (Positive control) 
ATCC Staphylococcus aureus 25923 (Negative control) 
 
STATISTICAL ANALYSIS: 
A statistical analysis was carried out using statistical package for social 
sciences (SPSS) and Epi-info software by a statistician. The proportional data 
of the cross sectional study was tested using Pearson’s Chi-square analysis 
test and Binomial proportion test. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Results 
 
 
 
TABLE 1 
AGE AND SEX DISTRIBUTION OF CASES (N=289) 
AGE IN 
YEARS 
MALE FEMALE TOTAL 
0-10 24 16 40 
11-20 17 27 44 
21-30 32 57 89 
31-40 35 24 59 
41-50 9 5 14 
51-60 14 13 27 
61-70 8 4 12 
71-80 4 - 4 
TOTAL 143(49.48%) 146(50.52%) 289 
 
TABLE 2 
DISTRIBUTION OF ORGANISMS 
ORGANISMS NO OF 
ISOLATES 
PERCENTAGE 
Staphylococcus aureus 89 54.26 
Klebsiella  pneumoniae 40 24.39 
Pseudomonas 
aeruginosa 
22 13.41 
Escherichia coli 5 3.04 
Enterococci 5 3.04 
Coagulase negative 
staphylococcus 
2 1.21 
Acinetobacter 1 0.6 
 
TABLE 3 
DISTRIBUTION OF ORGANISMS IN BURN WOUND 
ORGANISMS BURN  
WOUND 
PERCENTAGE  
Staphylococcus aureus 63 56.75 
Klebsiella pneumoniae 29 26.12 
Pseudomonas 
aeruginosa 
13 11.71 
Escherichia coli 1 0.90 
Enterococci 2 1.80 
Coagulase negative 
Staphylococcus  
2 1.80 
Acinetobacter 1 0.90 
 TABLE 4 
SENSITIVITY PATTERN OF STAPHYLOCOCCUS AUREUS 
ANTIBIOTICS STAPHYLOCOCCUS AUREUS  
N=89  (PERCENTAGE) 
Amoxycillin 45(50.56) 
Gentamicin 57(64.04) 
Ciprofloxacin 50(56.17) 
Erythromycin 36(40.44) 
Cefotaxime 58(65.16) 
Cephalexin 36(40.44) 
Piperacillin/tazobactum 61(68.53) 
Levofloxacin 81(91.01) 
Amikacin 82(92.13) 
Vancomycin 89(100%) 
 
TABLE 5 
SENSITIVITY PATTERN OF KLEBSIELLA PNEUMONIAE 
ANTIBIOTICS KLEBSIELLA 
PNEUMONIA  N=40 
(PERCENTAGE) 
Amikacin 36(90) 
Ciprofloxacin 34(85) 
Cephatoxime 10(25) 
Cephalexin 5(12.5) 
Piperacillin/tazobactum 20(50) 
Imipenem 24(60) 
Gentamicin 18(45) 
 
 TABLE 6 
SENSITIVITY PATTERN OF PSEUDOMONAS AERUGINOSA 
ANTIBIOTICS PSEUDOMONAS  
AERUGINOSA  N=22 
(PERCENTAGE ) 
Amikacin 18(81.81) 
Ciprofloxacin 13(59.09) 
Cephatoxime 8(36.36) 
Cephalexin 6(27.27) 
Piperacillin/tazobactum 12(54.54) 
Imipenem 22(100) 
Gentamicin 11(50) 
 
 
TABLE 7 
DETECTION OF MRSA BY OXACILLIN  SCREEN AGAR TEST. 
ZONE(mm) NO.OF ISOLATES PERCENTAGE (%) 
>14 (MSSA) 55 61.79 
<10 (MRSA) 34 38.21 
 
TABLE 8 
CONFIRMATION OF MRSA BY CEFOXITIN DISK TEST. 
ZONE(mm) NO.OF ISOLATES PERCENTAGE (%) 
>20 (MSSA) 53 59.55 
<19 (MRSA) 36 40.44 
 
TABLE 9 
RESISTANCE PATTERN OF MRSA ISOLATES TO ANTIBIOTICS. 
ANTIBIOTICS MRSA ISOLATES (N=36) 
PERCENTAGE (%) 
Amoxicillin 84.4 
Gentamicin 47.3 
Ciprofloxacin 41.7 
Erythromycin 48.4 
Cefotaxime 66.7 
Cephalexin 75 
Piperac illin/tazobactum 72.3 
Levofloxacin 2.8 
Amikacin 5.6 
Vancomycin 0 
TABLE 10 
NO OF ENTEROBACTERIACEAE RESISTANT TO 3
RD
 
GENERATION CEPHALOSPORINS. 
NUMBER OF ISOLATES RESISTANT TO 3
rd
 
GENERATION 
CEPHALOSPORINS 
 45  19 
TABLE 11 
ESBL DETECTION BY VARIOUS METHODS. 
 
 
 
TABLE 12 
 DISTRIBUTION OF  ESBL PRODUCING ENTEROBACTERIACEAE 
 
 
 
 
 
 
 
 
TABLE 13 
METHODS DDST MIC PCT 
Positive isolates n=19 19(100%) 19(100%) 19(100%) 
ORGANISMS TOTAL ESBL PERCENTAGE 
Klebsiella 
pneumoniae 
40 17 42.50 
Escherichia coli 5 2 40 
Total 45 19 41.25 
DISTRIBUTION OF  ESBL PRODUCING ENTEROBACTERIACEAE 
FROM VARIOUS WOUNDS. 
ORGANISM BURNS 
 
SSI 
 
TRAUMATIC 
WOUND 
 
ABSCESS 
 
TOTAL 
 
Total ESBL Total ESBL Total ESBL Total ESBL Total ESBL 
Klebsiella 
pneumoniae 
29 12 7 3 2 0 2 2 40 17 
Escherichia 
coli 
1 1 2 1 - - 2 - 5 2 
Total 30 13 9 4 2 - 4 2 45 19 
 
TABLE 14 
RESISTANCE PATTERN OF ESBL PRODUCERS TO OTHER 
ANTIBIOTICS. 
ANTIBIOTICS ESBL PRODUCERS( N=19)% 
Amikacin 10.5 
Ciprofloxacin 58 
Cefotaxime 89.5 
Cephalexin 95 
Piperacillin/tazobactum 79 
Imipenem 58 
Gentamicin 58 
 
 
TABLE 15 
MIC OF  ENTEROBACTERIACEAE TO CEFOTAXIME  AND 
CEFOTAXIME WITH CLAVULANIC ACID. 
CEFOTAXIME 
µG/ML 
NO OF 
ISOLATES 
INHIBITED 
CEFOTAXIME 
& 
CLAVULANIC 
ACID(2µG/ML) 
NO OF 
ISOLATES 
INHIBITED 
1 - 0.125 1 
2 - 0.25 3 
4 - 0.5 5 
8 - 1 4 
16 - 2 7 
32 3 4 4 
64 3 8 1 
128 5 16 1 
256 4 32 - 
512 6 64 - 
1024 8 128 2 
2048 9 256 - 
 
 
TABLE 16 
MIC OF ENTEROBACTERIACEAE TO CEFTAZIDIME AND 
CEFTAZIDIME WITH CLAVULANIC ACID. 
CEFTAZIDIME 
µG/ML 
NO OF 
ISOLATES 
INHIBITED 
CEFTAZIDIME 
& 
CLAVULANIC 
ACID(2µG/ML) 
NO OF 
ISOLATES 
INHIBITED 
1 - 0.125 2 
2 - 0.25 3 
4 - 0.5 5 
8 - 1 8 
16 - 2 7 
32 5 4 3 
64 6 8 1 
128 9 16 - 
256 9 32 - 
512 8 64 - 
1024 5 128 - 
2048 4 256 - 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
  
 
 
 
  
 
 
  
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 Specimens obtained from patients with wound infection attending 
Surgical, Orthopaedic,  Burns ward, OG,  IMCU,  Plastic surgery 
departments as OP and IP  were studied from March 2009 to Feb 2010 to 
identify  the bacteriological profile of wound infection, antimicrobial  
susceptibility pattern of the organisms isolated ,incidence of MRSA and 
ESBL producing Enterobacteriaceae  among them. Study included patients of 
both sexes and  up to 80 years of age .Specimen included were pus, wound 
swab. 
 Wound swabs from 289 patients were analyzed in the study. Male 
patients constituted 143(49.48%), Female patients constituted 146(50.51%), 
age ranged from 3 months to 80 years. Bacterial isolates were found in 164 
(56.74%). The isolation rate was significantly higher in females (51.21%), 
compared to males (48.78%). The predominant isolates were Gram positive 
bacteria 96(58.53%). The most frequently isolated organisms were 
Staphylococcus aureus 89(54.26), followed by Klebsiella pneumoniae 
(24.39%), Pseudomonas  aeruginosa 22(13.41%), Escherichia coli 5(3.04%), 
Enterococci 5(3.04%), Coagulase negative Staphylococcus 2(1.21%), 
Acinetobacter 1(0.60%). 
 
The results were analyzed as follows: 
 Total number of cases taken for study were 289, which included total 
of 143 males (49.48%) and 146 females(50.51%). Maximum cases were 
recorded in the age group between 21-30. In all age groups except  11-20 and 
21-30  the sex distribution was predominantly male.(Table 1) 
 Out of 289 samples collected, 164 showed culture positivity.The 
isolated organisms were Staphylococcus aureus 89(54.26%), followed by 
Klebsiella  pneumoniae 40 (24.39%), Pseudomonas  aeruginosa 22(13.41%), 
Escherichia coli 5 (3.04%), Enterococci 5 (3.04%)  Coagulase negative 
staphylococcus 2 (1.21%), Acinetobacter 1 (0.60%).(Table 2) 
 Out of 111 burn wound isolates,   63 (56.75%) were Staphylococcus 
aureus,    29(26.12%) were Klebsiella  pneumoniae, 13(11.71%) were 
Pseudomonas aeruginosa ,1(0.9%) were Escherichia coli, 1(0.9%) were 
Acinetobacter, 2(1.8%) were Enterococci, 2(1.8%) were  Coagulase negative 
Staphylococcus.(Table 3). 
 The organisms isolated from 26 specimen of surgical site infections 
were     Staphylococcus aureus 11(42.30%), Klebsiella pneumoniae 7 
(26.92%),   Pseudomonas aeuroginosa  3(11.53%),   Enterococci  3(11.53%),   
Escherichia coli  2 (7.6%).  
 Out of 22 cutaneous abscess isolates, 13(59.09%) were Staphylococcus 
aureus, 2(9.09%) were Klebsiella pneumoniae, 5(22.72%) were Pseudomonas 
aeruginosa, 2(9.09%) were Escherichia coli. 
 Out of 5 traumatic wound , 2(40%) were Staphylococcus aureus, 
2(40%) were Klebsiella pneumoniae, 1(20%) were Pseudomonas aeruginosa. 
 
Antibiotic sensitivity pattern : 
 Out of 89 Staphylococus aureus  45(50.56%) were sensitive to 
amoxycillin, 57(64.04%) were sensitive to gentamicin, 50(56.17%) sensitive 
to ciprofloxacin, 36(40.44%) were sensitive to erythromycin, 58(65.16%) 
were sensitive to cefotaxime, 36(40.44%) were sensitive to cephalexin, 
61(68.53%) were sensitive to piperacillin/tazobactum, 81(91.01%) were 
sensitive to levofloxacin, 82(92.13%) were sensitive to amikacin, and 100% 
sensitive to vancomycin.(Table 4). 
 Cogaulase negative Staphylococcus  were 100% sensitive to 
amoxycillin, gentamicin, erythromycin, cefotaxime, cephalexin, 
piperacillin/tazobactum, levofloxacin, amikacin vancomycin, and 50% 
sensitive to ciprofloxacin.  
 Out of 5 Enterococci, 4(80%) were sensitive to ciprofloxacin, 3(60%) 
were sensitive to amikacin, 2(40%) were sensitive to gentamicin, 
erythromycin, cefotaxime, cephalexin, levofloxacin  and 100% sensitive to 
vancomycin.  
 Out of 40 Klebsiella pneumoniae 36(90%) were sensitive to amikacin, 
34(85%) were sensitive to ciprofloxacin, 10(25%) were sensitive to 
cefotaxime, 5(12.5%) were sensitive to cephalexin, 20(50%) were sensitive 
to Piperacillin/tazobactum , 24(60%) were sensitive to imipenem, 18(45%) 
were sensitive to gentamicin.(Table 5) 
  Out of 22 Pseudomonas  aeruginosa,  18(81.81%) were sensitive to 
amikacin, 13(59.09%) were sensitive to ciprofloxacin, 8(36.36%) were 
sensitive to cefotaxime, 6(27.27%) were sensitive to cephalexin, 12(54.54%) 
were sensitive to Piperacillin/tazobactum, 22(100%) were sensitive to 
imipenem, 11(50%) were sensitive to gentamicin.(Table 6) 
 Out of 5 Escherichia coli , 4(80%) were sensitive to amikacin, 
imipenem, 3(60%) were sensitive to ciprofloxacin,2(40%) were sensitive to 
cephalexin, 1(20%) were sensitive to cefotaxime, piperacillin/tazobactum  
gentamicin. 
 Acinetobacter is 100% sensitive to imipenem and  
piperacillin/tazobactum. 
 
 
 
SCREENING FOR MRSA: 
Oxacillin disk (1 µg) 
All the 89 isolates of  Staphylococcus  aureus were screened for 
Methicillin resistance using oxacillin disk (1µg)  and out of them 34(38.21%) 
were found to have inhibition zone less than 10mm.(Table 7). 
Using Cefoxitin disk (30µg) 
All the 89 isolates of  Staphylococcus aureus were then further 
confirmed for Methicillin resistance using cefoxitin disk (30µg).(Table 8). 
The MRSA isolates were resistant to Amoxycillin(84.4%), 
Gentamicin(47.3%),Ciprofloxacin(41.7%),Erythromycin(48.4%),Cefotaxime
(66.7%),Cephalexin(75%), Piperacillin/tazobactum(72.3%), Amikacin(5.6%) 
Levofloxacin (2.8%) but not resistant  to vancomycin.(Table 9). 
 
SCREENING FOR ESBL: 
 Out of 45 Enterobacteriaceae isolates 19(42.22%)  found to be ESBL 
producers by screening method ,were subjected to further tests and by all 
methods were confirmed as ESBL producers.(Table 10 and Table 11) 
 Out of 40 Klebsiella  pneumoniae isolates, 17(42.50%) were ESBL 
producers. Out of   5 Escherichia coli isolates, 2(40%) were ESBL 
producers.(Table 12). 
 In burn wound out of  30  Enterobacteriaceae isolates, 13(43.33%) 
were ESBL producers. Out of 1 Escherichia coli isolate, 1(100%) were  
positive, out of 29 Klebsiella pneumoniae isolates, 12(41.37%) were ESBL 
producers.(Table 13). 
  In Surgical site infection out of 9 Enterobacteriaceae isolates, 
4(44.44%) were ESBL producers. Out of 7 Klebsiella pneumoniae 3(42.85%) 
were ESBL producers, out of 2 Escherichia coli isolates 1(50%) were ESBL 
producers.(Table 13). 
 In cutaneous abscess out of 4 Enterobacteriaceae isolates, 2 (50%) 
were ESBL producers. Out of 2 Klebsiella pneumoniae isolates, 2(100%) 
were ESBL producers.(Table 13) 
 The ESBL producers were resistant to amikacin(10.5%) 
gentamicin(58%),ciprofloxacin(58%),cefotaxime(89.5%), cephalexin (95%, 
Piperacillin/tazobactum(79%), imipenem(58%).(Table 14). 
 MIC for the isolates was between   32µg/ml to 2048µg/ml  of agar for 
cefotaxime and ceftazidime which was reduced to  0.125 to 128 µg/ml of 
agar respectively in the presence of 2 µg of clavulanic acid/ml of agar. 
(Table 15&16). 
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Discussion 
 
 
DISCUSSION 
 
 The control of wound infections has become more challenging due to 
widespread bacterial resistance to antibiotics and to greater incidence of 
infections caused by ESBL producing strains and MRSA. 
 The clinical microbiological laboratory has the task of screening and 
confirming isolates for ESBL production  and MRSA, therefore pus culture 
and antibiotic susceptibility testing plays an important role in the treatment of 
wound infection and also prevents from developing further complications. 
289 cases of both male and female from up to 80 years of age with various 
wound infection were included in this study which gives a ratio of  0.97 :1 
(143/146). 
 In developing countries like ours, inspite of strict aseptic precautions, 
vigorous antibiotic prophylaxis and meticulous surgical techniques wound 
infection is still a challenge to the surgeon however skilled he may be. 
  In the present study out of 289 specimens, 164 isolates were 
identified.(56.74%) 
 In the present study the organisms isolated from 26 specimen of 
surgical site infections were Staphylococcus aureus 11 (42.30%) Klebsiella 
pneumoniae  7  (26.92%), Pseudomonas aeruginosa  3 (11.53%), Enterococci  
3 (11.53%), Escherichia.coli  2 (7.6%).  
 Similar results were observed in the study by Jonathan isibor et al 
85,
 
the predominant bacterial isolate in SSI  was Staphylococcus aureus- 35%, 
followed by Pseudomonas  aeruginosa 7.4%, Escherichia coli 13%,. 
 In study by Eveline  geubbels et al
86
, the predominant isolate was 
Staphylococcus aureus (35%). 
 A study by Jyoti sonawane
87
 et al the predominant isolate in SSI was 
Staphylococcus aureus which was (29.26% ) followed by Escherichia coli 
(18.70%), Pseudomonas aeruginosa (15.3%). 
 In Shittu et al  and Brook  et al 
88, 89 
studies ,Staphylococcus aureus  
was the predominant organism isolated from surgical site infections ,22.22% 
and 26.54% respectively . Data from the national nosocomial infections 
survelliance system
90
.reveals that most common incisional SSI pathogens are 
Staphylococcus aureus, Enterococcus, Enterobacteriaceae, Pseudomonas 
aeruginosa . 
 In SP Lilani
91
 et al study the predominant isolate in SSI was 
Staphylococcus aureus  followed by Pseudomonas aureginosa. In study by 
Mangram,  Pearson 
92
 et al and  study by  Prabhakar et al 
93
the predominant 
isolate in SSI was Staphylococcus aureus.  
 In a study by Arti kapil
94
 the predominant  isolate in SSI was 
staphylococcus aureus  which was  40% followed by  Pseudomonas 
aeruginosa  12%, Escherichia coli -11%, Klebsiella pneumoniae 8%. 
 In a study by Hayath kowner
95
, the predominant  isolate in SSI was 
staphylococcus aureus  which was 23.37%  followed by  pseudomonas 
aeruginosa   23.37% , Escherichia coli 4.8%, Klebsiella pneumoniae 8%. 
 In a study by Prabhat ranjan 
96
the predominant isolate in SSI was 
Pseudomonas aeruginosa  29.6%,  Escherichia coli 20.3%, Klebsiella 
pneumoniae 16.6%, Staphylococcus aureus 14.3% which is contrast to our 
study. 
 In the present study  the  prevalence of Klebseilla pneumoniae in  
surgical site infections were 26.92%. 
 Similar results were observed in a study  by  Rezwana haque et al
97
 in 
which  the prevalence of Klebsiella  pneumoniae were 26.76%. 
 The results  in contrast to our study  were observed .In a study by 
Prabhat ranjan
96
 et al the prevalence of Klebsiella  pneumoniae were 
16.6%.In a study by  Jyoti  sonawarne et al
87
 the prevelance of Klebsiella 
pneumonia were 14.07% .In a study by Arti kapil et al 
94
the prevalence of 
klebsiella  pneumonia were 8%. This shows that there is increase in the 
prevalence of Klebsiella pneumoniae  in the present. 
 The aerobic isolates of burn wound in the present study included 
Staphylococcus aureus 63(56.75%), kKebsiella pneumonia  29(26.12%), 
Pseudomonas aeruginosa 13(11.71%), Enterococci 2(1.8%), Coagulase 
negative Staphylococcus  2(1.8%), Escherichia coli 1(0.9%) and 
Acinetobacter (0.9%).  In concordance with our study, in  the  study by Misra 
et al
98
 the commonest pathogen isolated was Staphylococcus aureus (60%).   
In the study by  Revathi et al 
99
the predominant isolates was Staphylococcus 
aureus . %. In a study by  S.Vidhani et al 
100
the predominant isolate was  
Staphylococcus aureus 41.8%. 
 A study by NP Singh et al
101
 the predominant isolate in burns wound 
was pseudomonas aeruginosa 31% followed by staphylococcus aureus 22% 
and klebseilla pneumonia 19% which is contrast to our study. A study by 
Manjula et al
102 
shows contrast observation in which Pseudomonas 
aeruginosa  was the commonest pathogen isolated from burns wound(51.5%) 
and Staphylococcus aureus was 11.15%. In  another study by Ekrami and 
Kalantar et al
103
 Pseudomonas  aeruginosa was the commonest pathogen .In a 
study by Shankar srinivasan et al
104
 the predominant isolate in burns wound 
was Klebseilla pneumonia  33.91%..  In contrast in study by Herjinder kaur et 
al
105
 the predominant isolate was Pseudomonas aeruginosa 19%. In a study 
by Agnihotri et al
106
 the predominant isolate was  Pseudomonas aeruginosa   
59%, followed by Staphylococcus aureus  17.9%, Klebsiella pneumonia 
3.9%. 
 The predominant aerobic isolate obtained from 22 specimen of 
cutaneous abscess was Staphylococcus aureus 13(59.09%). The other isolates 
obtained were  Pseudomonas aeruginosa 5(22.72%), Klebsiella pneumoniae  
2(9.09%), Escherichia coli 2(9.095). This correlates with the study of Brook 
and Frazier
107
 where Staphylococcus aureus (30.76%) was the  commonest 
isolate .In another study by Brook and Finegold also  Staphylococcus aureus 
108
 (42.58% )was the commonest isolate .In another study by Fantahun 
biadglegne et al
109
the predominant isolate was Staphylococcus aureus 69.7%. 
  The aerobic isolates of traumatic wound in the present study included 
Staphylococcus aureus  2(40%), Klebseilla pneumoniae   2(40%), 
Pseudomonas  aeruginosa  1(20%). s  29.14%. In Akinjogunla et al 
134 
study 
the predominant isolate were Staphylococcus aureus 37.8%, Pseudomonas  
aeruginosa 27%  which correlates with our study.  In Shittu et al 
88
 study the 
predominant isolates were Staphylococcus aureus  25%.In contrast , in Brook 
and Frazier
107
 study the predominant isolates were Escherichia coli  22.55%, 
Staphylococcus aureus 16.57% Klebsiella pneumonia  4.34% .  
 The antibiotic sensitivity pattern of Staphylococcus aureus in our study  
shows , 45(50.56%) sensitive to amoxycillin, 57(64.04%) were sensitive to 
gentamicin, 50(56.17%) sensitive to ciprofloxacin, 36(40.44%) were 
sensitive to erythromycin, 58(65.16%) were sensitive to cefotaxime, 
36(40.44%) were sensitive to cephalexin, 61(68.53%) were sensitive to 
piperacillin/tazobactum, 81(91.01%) were sensitive to levofloxacin, 
82(92.13%) were sensitive to amikacin.  
 Similar results were observed  in the study by Sarita yadav et al 
110
 
sensitivity pattern of Staphylococcus aureus was 48.31% to erythromycin, 
53.93% to cephalexin. In a study by Misra et al 
98
sensitivity pattern of 
Staphylococcus aureus was 59% to cefotaxime, 56% to gentamicin, 75% to 
ciprofloxacin. In a study by shilpa arora et al
111 
sensitivity pattern of 
Staphylococcus aureus was 78% to amikacin, 46% to gentamicin, 47.2% to 
ciprofloxacin, 43.2 % to cephalexin. 
  In contrast to our study ,in  the study by Fantahun biadglegne et al 
109
the  sensitivity of staphylococcus aureus  to erythromycin and gentamicin  
showed 70% and 75.7% respectively. In a study by Sanjay dhar et al 
112
sensitivity pattern of Staphylococcus aureus was  20% to amikacin, 
26.66% to ciprofloxacin. ,. In a study by Jonathan osariemen isibor et al 
85
sensitivity pattern of Staphylococcus aureus was 15.8% to ciprofloxacin, 
63.2 % to gentamicin, 15.8% to cephalexin,  63.2 % to erythromycin. 
 The antibiotic sensitivity pattern of Klebsiella pneumoniae in our study 
shows ,  36(90%) were sensitive to amikacin, 34(85%) were sensitive to 
ciprofloxacin, 10(25%) were sensitive to cephotoxime, 5(12.5%) were 
sensitive to cephalexin, 20(50%) were sensitive to piperacillin/tazobactum , 
24(60%) were sensitive to imipenem, 18(45%) were sensitive to 
gentamicin.similar results observed  in the  study by Shankar srinivasan  et 
al
104
 sensitivity pattern of Klebseilla pneumonia was 66.9% to amikacin. In a 
study by sanjay dhar 
112
 sensitivity pattern of Klebseilla pneumonia was 
100% to amikacin, 33.33% to ciprofloxacin.  
 In contrast to our study  , in the  study by Jonathan osariemen isibor et 
al 
85
sensitivity pattern of Klebsiella pneumonia was 50% to ciprofloxacin , 
50% to cephalexin, 100% to gentamicin. In a  study by Jyoti sonawane  et al
87
 
sensitivity pattern of Klebsiella pneumonia  was 37.62% to ciprofloxacin, 
47.37% to gentamicin, 100% to imipenem.  
 The antibiotic sensitivity pattern of  Pseudomonas  aeruginosa   in our 
study shows , 18(81.81%) were sensitive to amikacin, 13(59.09%) were 
sensitive to ciprofloxacin, 8(36.36%) were sensitive to cephotaxime, 
6(27.27%) were sensitive to cephalexin, 12(54.54%) were sensitive to 
piperacillin/tazobactum, 22(100%) were sensitive to imipenem, 11(50%) 
were sensitive to gentamicin. Similar results were observed  in the  study by 
Shankar srinivasan  et al
104
 sensitivity pattern was 62.3% to amikacin. . In a 
study by Sanjay dhar  et al 
112
 sensitivity pattern of Pseudomonas  aeruginosa   
was 65% to amikacin, 30% to ciprofloxacin. In a  study by Jyoti sonawane  et 
al
87
 sensitivity pattern of Pseudomonas  aeruginosa   was 54.22% to 
amikacin, 96.38% to imipenem. In a study by Jonathan osariemen isibor et al 
85
sensitivity pattern of  Pseudomonas  aeruginosa   was 35.7% to 
ciprofloxacin, 71.4% to gentamicin, 28.5% to cephalexin. 
  In a study by Fantahun biadglegne et al 
109
sensitivity of  Pseudomonas  
aeruginosa to gentamicin was 67%. In a study by Prabhat ranjan  et 
al
96
sensitivity pattern of  Pseudomonas  aeruginosa  was 76.9% to imipenem, 
53% to amikacin, 36% to ciprofloxacin, 29.1% to gentamicin. In the  study 
by shampa anupurba et al
113
, the prevalence of pseudomonas aeruginosa in 
wound infection was  32% and were sensitive to  ciprofloxacin 58%. 
 In contrast to our study , in the  study by Misra et al 
98
sensitivity 
pattern of  Pseudomonas  aeruginosa   was 67% to cefotaxime, 12 % to 
getamicin, 60% to amikacin, 47% to ciprofloxacin.in a study by sp lilani  et 
al
91
 Pseudomonas  aeruginosa was  100% resistance to gentamicin. In a study 
by Manjula Mehta et al 
102
sensitivity pattern of  Pseudomonas  aeruginosa   
was 15% to amikacin, 11% to gentamicin, 21% to ciprofloxacin. 
 The antibiotic sensitivity pattern of  Escherichia coli  in our study 
shows,   4(80%) were sensitive to amikacin, imipenem, 3(60%) were 
sensitive to ciprofloxacin,2(40%) were sensitive to cephalexin, 1(20%) were 
sensitive to cephotaxime, pipercillin/tazobactum ,gentamicin. In a study by 
Shankar srinivasan  et al
104 
sensitivity pattern of  Escherichia coli  was 42.7% 
to amikacin. . In a study by Sanjay dhar et al 
112  
sensitivity pattern  of  
Escherichia coli   was 50% to amikacin, 30% to ciprofloxacin. In a study by 
Jonathan osariemen isibor et al
85
 sensitivity pattern of    Escherichia coli  was 
85.7% to ciprofloxacin, 57.1% to gentamicin, 85.75% to cephalexin. 
 In a study by Misra et al 
98
sensitivity pattern of  Escherichia coli  was 
65% to cefotaxime, 89% to amikacin, 35% to gentamicin, 19% to 
ciprofloxacin. In a study by Fantahun biadglegne et al 
109
sensitivity of  
Escherichia coli  to gentamicin was 75%.. In a  study by Jyoti sonawane  et 
al
87
 sensitivity pattern of  Escherichia coli  was 13.86% to ciprofloxacin, 
49.5%  to gentamicin, 99.01% to imipenem. 
 MRSA is a major nosocomial pathogen causing significant morbidity 
and mortality
114
.The important reservoirs of MRSA in hospitals/institutions 
are infected or colonized patients and transient hand carriage on the hands of 
health care workers is the predominant mode for patient to patient 
transmission.
115
 
 The percentage of MRSA isolated in our study was 40.44%   similar 
results were observed  . In the study by Arti kapil  et al
94
 the MRSA was 
30%. In the study by Shilpa arora et al
111
 which was 46%. In the study 
Vidhani et al 100the MRSA was found to be 51.6%. In the study by Sarita 
yadav et al 
110
 methicillin resistance was documented in 60.6% of 
Staphylococcus aureus isolates which was alarmingly high prevalence of  
MRSA. 
 In contrast  in the    study  Jyoti sonawane  et al
87
 prevalence  of MRSA 
was 27.85%. In a study by Hayath kowner
95
, MRSA  isolated was 21.7%.a 
study by Srinivasan et al 
135 
33.33% of staphylococcus isolates was identified 
as MRSA. 
 In the  study  on spectrum of antimicrobial resistance among MRSA, 
ciprofloxacin resistance was as high as 90% and Qureshi et al 
116
 had reported 
the same as 98.9%. In contrast in our study   44%  of the strains  are resistant 
to ciprofloxacin.  Pulimood 
117
had observed only 8% resistance of MRSA   to 
gentamicin  as against  44% in our study. Qureshi 
116
had reported  gentamicin 
resistance of 97.8% which is high compared to our study.  
 In our study we  obtained high percentage of multidrug resistant 
MRSA .Majumder et al
118
 from assam had reported 23.2% of the MRSA  
isolated found  to be multidrug resistant. Anupurba et al 
119
from uttar Pradesh 
had reported a higher percentage of multidrug resistant MRSA.  
 Vidhani et al 
100
from delhi reported even a higher percentage of 
multidrug resistant MRSA.. In the study by Misra et al
98
 MRSA isolates were 
resistance to erthyromycin (69%),  66.6%to gentamicin, 40% to 
ciprofloxacin, 69.2% to cefotaxime. In the study by Rajaduraipandi et al
120
 
the MRSA isolates were resistant to gentamicin 62%, cephalexin 60.8%, 60% 
to erythromycin. 
 This variation might be because of several factors like efficacy of 
infection control practices, healthcare facilities and antibiotic usage that 
vary from hospital to hospital.  
 The percentage of MDR strains among MRSA was found to be  in   
various reports from other parts of the country, the burden of such strains 
has ranged from 23.2% to 32% to 63.6%.118, 119,120 I 
 In the study by vidhani et al
100
 the antibiotic sensitivity pattern of 
MRSA isolates were 11.5% to amoxicillin, 21.5% to cefotaxime, 17.7% to 
erythromycin, 26.6% to amikacin, 67% to ciprofloxacin. 
 In the study by hare Krishna tiwari et al
121 
 the MRSA isolates  was 
38.44% and they  were resistant to  gentamicin 56.14%, amikacin 42.98%, 
75.56% to ciprofloxacin, 72.81% to  erythromycin. 
The most effective way to prevent MRSA infections is by doing continuous 
surveillance of antibiotic resistance profiles of local Staphylococcus aureus  
isolates to formulate antibiotic policies and effective infection control 
practices. 
 Extended spectrum beta lactam antimicrobial drugs are commonly 
included in empirical antibiotic regimen for treatment of Gram negative 
sepsis but the emergence of ESBL producing bacteria poses a serious threat 
to the continued use of this family of antibiotics 
122.
  
 Therefore , infections caused by ESBL isolates need to be addressed 
with a general consensus in order to overcome the challenge of infection 
management worldwide .  
 There have been sporadic reports of ESBLs from major hospitals in 
India and some of them recorded the incidence to be as high as 60-68% 
(Mathur et al)
124
 the unusually high incidence of ESBLs should be a cause of 
concern to the regulators of the hospital antibiotic policy. Over reliance on 
third generation cephalosporins to treat Gram  negative infections is one of 
the prime factors responsible for increased resistance to this class of 
antibiotics. 
 In our study the ESBL producing Enterobacteriaceae  were 19 
(42.22%) .In the study by C Rodrigues et al 
125
 the prevalence of ESBL was 
53%.The occurrence of ESBL producing Klebsiella pneumoniae accounts for 
42.5%  in our study and E.coli was 40% which is correlating with the study 
of Ashwin et al 
126
43.75% and 58.06% respectively. ESBLs among Klebsiella  
pneumoniae of this study also correlates with Leblebicioglu study
127
 
(50%),and in  Ozgunes study 
128
it was 47%.  
 But in contrast , a study by Shukla et al
129
 showed 36.1%  of  ESBL 
producing Klebsiella pneumoniae. In a study by C Shanmuganathan et  al
130
 , 
there was an outbreak of ESBL producing  Klebsiella pneumoniae. In 
contrast  to our study the study by MS kumar et al
131
  the ESBL producing 
Klebsiella pneumoniae was 14% and  ESBL producing Escherichia coli was 
63.7%. 85% of Klebsiella pneumoniae exhibited an MIC of 256 µg/ml to 
cefotaxime. 95% of Escherichia coli exhibited an MIC of 256µg/ml to 
cefotaxime. 
  In the study by Shukla et al 
129
the prevelance  of ESBL producing 
Klebsiella pneumonia  was  30.18%.The MIC of 3
rd
 generation 
cephalosporins test antibiotics against ESBL producers ranged between 2 to 
128µg/ml. 
   In a study Rezwana haque et al 
97
the percentage of  ESBL producing 
bacteria was 46.67% and highest rate was found in Klebsiella pneumonia 
(57.89%)  followed by Escherichia coli (47.83%),  which correlates with our  
study  ESBL was 42.22% and  Klebsiella  pneumoniae ( 42.50%) and 
Escherichia coli (40%.) 
 In the postoperative wound infections the occurrence of ESBL 
producers in the study were33.33% which correlates with the Ashwins et al 
126
 study (22.4%). 
 In our study , 89.5% of ESBL positive bacterial strains were sensitive 
only to amikacin, while they showed significantly increasing resistance to all 
other antibiotics used, which implies that ESBL producing organisms are 
multidrug resistance. The prevalence of these multidrug resistant ESBL 
strains is also reported to be on the rise.
123
 
 The resistance pattern of ESBL producers in our study were 79% to 
piperacillin/tazobactum  and 58% to gentamicin , ciprofloxacin, imipenem  
but 89.5% sensitive to amikacin   which correlates with study by Baby 
padmini et al
133
 where sensitivity of ESBL producers to amikacin was 82.6%. 
In the study by Dechen c tsering et al
132
 the prevalence of ESBL  was 34%. 
The ESBL producers were resistant to 51.9% to piperacillin/tazobactum, and 
ciprofloxacin, 54.3% to gentamicin. 
  The resistance pattern of ESBL producers in a study by Rezwana 
haque  et al 
97
was 100%  to ampicillin,  81.82% to ciprofloxacin, 45.45% to 
gentamicin, but  100% sensitive to imipenem. 
 In a study by Jyoti sonawane et al 
87
 the ESBL isolates were frequently  
resistant  to  other antibiotics but showed nearly 100% sensitive to 
piperacillin/tazobactum and imipenem. 
Minimum inhibitory concentrations (MIC) of Cefotaxime and 
Ceftazidime and of Cefotaxime and Ceftazidime with 2 µg/ml of Clavulanic 
acid by agar dilution method for ESBL producers. (N=19) 
MIC of cefotaxime and ceftazidime for ESBL producing 
enterobacteriaceae isolates was between 32-2048 mg/ml of agar. MIC of 
cefotaxime for ESBL producing isolate was between 0.125 -128 mg/ml of 
agar in the presence of clavulanic acid at a concentration of 2mg/ml of agar 
showing 8 fold reductions in MIC. MIC of ceftazidime for ESBL producing 
isolate was between 0.125 -128 mg/ml of agar in the presence of clavulanic 
acid at a concentration of 2mg/ml of agar showing 8 fold reductions in MIC. 
Monitoring and judicious usage of extended spectrum cephalosporins , 
periodic surveillance of antibiotic resistance patterns and efforts to decrease 
empirical antibiotic therapy would go a long way in addressing some of the 
problems associated with ESBLs. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Summary 
 
 
 
 SUMMARY 
 
  Two hundred and eighty nine patients with wound infection between 
March 2009 and February 2010 formed the study group. Specimens  
obtained from patients were cultured and bacterial pathogens were 
identified by Gram staining and various biochemical reaction. 
 The predominant  isolates of  wound infection were Staphylococcus 
aureus 89(54.26%) followed by Klebsiella pneumonia 40(24.39%), 
Pseudomonas aeruginosa 22(13.41%). 
 All 89 isolates of Staphylococcus aureus were screened for methicillin 
resistance using oxacillin disc (1µg) and confirmed using cefoxitin 
disk(30µg)The percentage of MRSA  was found to be 40.44%. and 
were susceptible to vancomycin(100%), levofloxacin (97.2%), 
amikacin (94.4%). 
 Antibiotic susceptibility testing was done with appropriate antibiotics 
including third generation cephalosporins and the Enterobacteriaceae 
isolates were screened for ESBL production by disk diffusion 
method(as per CLSI guidelines) and double disk synergy test. ESBL 
producers were confirmed by phenotypic confirmatory test and 
minimum inhibitory concentration determination by agar dilution 
method. 
  Out of 45 Enterobacteriaceae isolates 19(42.22%) were found to be 
ESBL producers and  were susceptible to amikacin(89.5%). 
 MIC for the isolates was between   32µg/ml to 2048µg/ml  for 
cefotaxime and ceftazidime which was reduced to  0.125 to 128 µg/ml 
respectively in the presence of 2 µg of clavulanic acid/ml of agar. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
 
 CONCLUSION 
 The predominant isolate was found to be Gram positive bacteria 96 
(58.53%)  than  Gram negative bacteria 68 (41.46%).However 
Staphylococcus aureus 89 (54.26%) was seen as the most common 
bacterial pathogen followed by Klebsiella pneumoniae 40 (24.39%) 
and Pseudomonas aeruginosa 22 (13.41%) 
 Among  the Staphylococcus aureus 36 (40.44%) were found to be  
MRSA and were susceptible to vancomycin (100%), levofloxacin 
(97.2%), amikacin (94.4%). 
 Detection of MRSA were  found to be high with cefoxitin disk than 
oxacillin screen agar . 
 Among Enterobacteriaceae isolates 19 (42.2%) were found to be ESBL 
producers and were susceptible to amikacin (89.5%).  
 By employing standard microbiological techniques meticulously the 
causative agents can be isolated and  antimicrobial sensitivity can be 
assessed for proper management of wound infection. 
 Essential infection control practices  including  hand washing by 
hospital personnel and  provides  better  control  of antibiotic resistant 
strains. 
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PROFORMA 
 
 
NAME           : 
 
AGE/SEX         : 
 
OP/IP NO: 
 
WARD: 
 
DATE OF ADMISSION: 
 
OCCUPATION: 
 
PRESENT COMPLAINTS: 
 
PAST HISTORY :  DIABETES MELLITUS: 
          HYPERTENSION: 
          CORONARY HEART DISEASE: 
 
CLINICAL FINDINGS: 
 
DIAGNOSIS: 
 
INVESTIGATIONS: 
 
TREATMENT AND MANAGEMENT: 
 
 
 
 
 
APPENDIX 
 
1.STAINS AND REAGENT: 
GRAMS STAIN: 
Reagents 
1. primary stain- crystal violet 10g 
   Absolute alcohol 100ml 
   Distilled water 1 litre 
2. Iodine solution- iodine 10g 
   Potassium iodide 20g 
   Distilled water 1 litre 
3. Acetone 
4 .Counter stain- dilute carbol fuchsin 
Procedure 
1. Flood the  fixed smear with crystal violet for one minute 
2. Rinse gently with distilled water 
3. Flood the slide with grams iodine for one minute 
4. Rinse gently with distilled water 
5. Decolourise with acetone for only 2-3 seconds. 
6. Rinse the slide with distilled water to remove excess decoluriser 
7. Flood the slide with dilute carbol fuchsin for 30 seconds. 
8. Rinse the slide with distilled water, air dry and examine under oil 
immersion objective of the microscope. 
2.MEDIA USED: 
 
1. PEPTONE WATER: 
Peptone        10g 
Sodium chloride                        5 g 
Distilled water                        1 Litre 
Dissolve the ingredients in warm water, adjust  the ph to 7.4 to 7.5 and filter. 
Distribute as required and autoclave at 121° c for 15 minutes. 
 
2. NUTRIENT AGAR: 
Ingredients  Grams per Litre 
Peptic digest of animal tissue                 5 
Sodium chloride                                        5 
Beef extract                                              1.5 
Yeast extract                                             1.5 
Agar                                                          15  
Final ph at 25°c , 7.4±0.2 
Suspend  28  grams  in 1000 ml of distilled water.  Heat  to  boiling to 
dissolve the medium completely. Sterilize by autoclaving  at 15 lbs pressure 
121°c for 15 minutes and pour into sterile Petridishes. 
3.BLOOD AGAR: 
Sterile sheep blood                                                      5ml 
Nutrient agar                                                             100 ml 
 Autoclave the Nutrient agar at 121°c for 15 minutes. Cool to 45-50°c and 
add blood with sterile precautions and distribute in Petri dishes. 
4.MACCONKEY AGAR: 
Ingredients                                                        Grams per Litre 
Peptic digest of animal tissue                       17 
Proteose peptone                                                             3 
Lactose                                                                            10  
Bile salts        1.5 
Sodium chloride       5 
Neutral red          0.03 
Agar       15 
Final ph at 25°c 7.1±0.2 
Suspend 51.53 grams  in 1000ml of distilled water . Heat to boiling to 
dissolve the medium completely. Sterilize by autoclaving   at 15 lbs pressure 
121c for 15 mts and pour into sterile petridishes. Mix well before pouring. 
5. MUELLER HINTON AGAR: 
Ingredients                                                               Grams per Litre 
Beef infusion     300 
Casein acid hydrolysate     17.50 
Starch        1.5 
Agar     17.00 
Final ph at 25°c 7.3±0.2  .Suspend 38 grams in 1000 ml distilled water. Heat 
to boiling to dissolve the medium completely. Sterilize by autoclaving   at 15 
lbs pressure 121°c for 15 minutes and pour into sterile Petridishes. Mix well 
before pouring. Pour 0-25 ml of it into petridishes of 9cm diameter to give a 
thickness of 4mm. 
6. MANNITOL SALT AGAR: 
Peptone     10g 
Meat extract     50g 
Mannitol     10g  
Sodium chloride    75g 
Distilled water    1 litre 
Phenol red 
Sterilize by autoclaving   at 15 lbs pressure 121c for 15 mts and pour into 
sterile petridishes. 
7. INDOLE TEST MEDIUM: 
Peptone     20g 
Sodium chloride      5g 
Distilled water     1 litre 
pH was  adjusted to 7.4 Sterilize by autoclaving   at 15 lbs pressure 121c for 
15 mts 
8. SIMMONS CITRATE MEDIUM: 
Sodium chloride      5g 
Magnesium sulphate     0.2g 
Ammonium dihydrogen phosphate    1g 
Potassium dihydrogen phosphate   1g 
Sodium citrate      5g 
Bromothymol blue(0.2%)    40ml 
Distilled water      1 litre 
Sterilize by autoclaving   at 15 lbs pressure 121c for 15 mts in a flask and 
distribute as slopes in sterile test tubes. 
9. CHRISTENSENS UREASE MEDIUM: 
Peptone       1g 
Sodium chloride      5g 
Di potassium hydrogen phosphate   2g 
Phenol red(1 in 500 aqueous solution)   6ml    
Agar        20ml 
Distilled water      1 litre 
Glucose 10% solution 
Urea 20% solution 
Sterilize the glucose and urea solution by filteration. Prepare the basal 
medium without glucose or urea. Adjust the pH to 6.8-6.9 and Sterilize by 
autoclaving   at 15 lbs pressure 121c for 15 mts in a flask. Cool to about 50°c 
. Add glucose and urea solution and por as deep slopes in tubes. 
 
10. TRIPLE SUGAR IRON AGAR: 
Beef extract      3g 
Yeast extract     3g  
Peptone      15g 
Proteose peptone     5g 
Lactose      10g 
Glucose      1g 
Sucrose      10g 
Ferrous sulphate     0.2g 
Sodium chloride     5g 
Agar       12g 
Phenol red      0.024g  
Distilled water     1 litre 
Heat to dissolve the solids; add the indicator solution; mix and tube. Sterilize 
by autoclaving   at 15 lbs pressure 121c for 15 mts  and cool to form slopes 
with deep(3cms) butts 
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MASTER CHART 
S.NO AGE SEX OP/
IP 
SPECIME
N 
ORGANISM ESBL MRSA Am G Cf E Ce Cp I Le Ak pipt ox van 
1.  22 F Ip Ws Stap.au   S S S      S  S S 
2.  38 F Ip Ws NG               
3.  48 M Ip Ws Stap.au    S       S  S S 
4.  8  M Ip Ws Staph.au    S       S  S S 
5.  17 M Ip Ws Stap.au   S S S S S S  S S  S S 
6.  30 F Ip Ws Kleb.pn E    S    S  S    
7.  8 M Ip Ws Stap.au         S S   S S 
8.  14 F Ip Ws NG               
9.  24 M Ip Ws Stap.au  +  S   S S  S S  R S 
10.  15 M Ip Ws NG               
11.  32 M Ip Ws Stap.au  + S S S S S S S S S  R S 
12.  32 M Ip Ws Stap.au    S S     S S  S S 
13.  22 M Ip Ws Kleb.pn     S      S S   
14.  7 M Ip Ws Stap.au          S S  S S 
15.  26 M Ip Ws Stap.au     S     S S  S S 
16.  14 F Ip Ws Stap.au  +   S     S S  R S 
17.  23 F Ip Ws Stap.au   S       S S  S S 
18.  28 F Ip Ws Kleb.pn E          S S   
19.  40 M Ip Ws Stap.au          S S  S S 
20.  20 F Ip Ws Stap.au    S      S S  S S 
21.  8 F Ip Ws Stap.au    S      S S  S S 
22.  18 M Ip Ws Stap.au    S S  S   S S  S S 
23.  19 F Ip Ws Stap.au  +  S S S S S S S S S R S 
24.  48 M Ip Ws Stap.au    S     S S S  S S 
25.  8 F Ip Ws NG               
26.  3 M Ip Ws NG               
27.  60 M Ip Ws NG               
28.  23 F Ip Ws NG               
29.  17 M Ip Ws NG               
30.  21 F Ip Ws NG               
31.  1  M Ip Ws NG               
32.  70 M Ip Ws Stap.au  +   S S  S  S S  R S 
33.  38 F Ip Ws Pseudo         S      
34.  24 M Ip Ws NG               
35.  57 F Ip Ws E.coli    S S  s        
36.  22 M Ip Ws Pseudo    S S S S  S S S S   
37.  25 F Ip Ws Ps.ar         S      
38.  60 M Ip Ws NG               
39.  34 F Ip Ws Stap.au      S S    S  S S 
40.  19 M Ip Ws Kleb.pn E        S      
41.  30 M Ip Ws Stap.au  + S S S S S S S S S S R S 
42.  61 M Ip Ws NG               
43.  60 M Ip Ws NG               
44.  7 M Ip Ws NG               
45.  30 F Ip Ws NG               
46.  13 M Ip Ws Kleb E   S S  S S S  S S   
47.  26 F Ip Ws NG               
48.  2.5 F Ip Ws NG               
49.  31 M Ip Ws NG               
50.  41 F Ip Ws NG               
51.  26 F Ip Ws E.coli    S S      S    
52.  60 F Ip Ws Stap.au  +   S     S   R S 
53.  7 M Ip Ws NG               
54.  33 F Ip Ws Stap.au    S   S   S   S S 
55.  33 M Ip Ws Stap.au  +  S S S S  S S S S R S 
56.  7 M Ip Ws Stap.au    S S S S S S S S S S S 
 21 F Ip Ws NG               
57.  4 F Ip Ws NG               
58.  13 M Ip Ws NG               
59.  24 F Ip Ws NG               
60.  20 F Ip Ws Stap.au  +  S S S S S S S S S R S 
61. s 29 F Ip Ws E.coli    S     S  S S   
62.  56 F Ip Ws Stap.au    S S S S S S S S S S S 
63.  65 M Ip Ws NG               
64.  23 F Ip Ws NG   Am G Cf E Ce Cp I Le Ak pipt   
65.  23 M Ip Ws Pseudo    S  S S S S S S S   
66.  64 M Ip Ws Kleb E   S S      S    
67.  36 M Ip Ws NG               
68.  35 M Ip Ws Stap.au  + S S S  S S S S S S R S 
69.  21 F Ip Ws NG               
70.  20 F Ip Ws NG               
71.  48 M Ip Ws Stap.au   S S S S  S S S S S S S 
72.  70 F Ip Ws NG               
73.  22 M Ip Ws Stap.au  +        S S  R S 
74.  8 F Ip Ws NG               
75.  20 M Ip Ws NG               
76.  24 F Ip Ws NG               
77.  34 M Ip Ws NG               
78.  25 M Ip Ws NG               
79.  16 M Ip Ws Stap.au   S S S S S S S S S S S S 
80.  10 M Ip Ws NG               
81.  35 M Ip Ws NG               
82.  27 F Ip Ws PS.ar     S S S S S S S S   
83. s 25 M Ip Ws NG               
84.  55 M Ip Ws Kleb.pn E   S       S    
85.  24 F Ip Ws Stap.au  +  S S  S   S   R S 
86.  28 M Ip Ws Stap.au    S S S S S S S S S S S 
87. S 78 M Ip Ws Kleb.pn E   S S  S    S    
88.  60 M Ip Ws entero     S     S     
89.  36 M Ip Ws Stap.au    S      S S  S S 
90.  28 M Ip Ws Stap.au  +  S  S    S S  R S 
91.  56 M Ip Ws Kleb.pn    S S     S S    
92.  48 M Ip Ws Kleb.pn     S    S  S S   
93.  24 M Ip Ws Stap.au    S S S S  S S S S S S 
94.  22 M Ip Ws Ps.ar    S     S  S    
95.  36 M Ip Ws Stap.au    S S  S  S S S S S S 
96.  3 M Ip Ws Stap.au    S S  S   S S  S S 
97.  40 M Ip Ws Stap.au  +   S  S  S S S S R S 
98.  36 M Ip Ws NG               
99.  36 F Ip Ws Stap.au  +   S S S  S S S S R S 
100.  32 F Ip Ws NG               
101.  8 F Ip Ws Stap.au  +   S     S S  R S 
102.  21 F Ip Ws Ps. ar         S  S    
103.  30  M Ip Ws Kleb.pn         S  S S   
104.  33 F Ip Ws Kleb.pn E    S    S  S S   
105. s 20 F Ip Ws Stap.au  +        S S  R S 
106.  35 M Ip Ws Stap.au          S   S S 
107.  8 F Ip Ws Kleb.pn E        S   S   
108.  40 F Ip Ws Kleb.pn    S S  S    S    
109.  55 F Ip Ws NG               
110.  28 F Ip Ws NG               
111.  40 F Ip Ws Stap.au  +  S      S S  R S 
112.  27 F Ip Ws Kleb.pn    S       S    
113.  35 F Ip Ws NG               
114.  36 M Ip Ws Stap.au  +   S    S S S  R S 
115.  30 F Ip Ws NG               
116.  20 F Ip Ws Stap.au  +        S S  R S 
117.  7 F Ip Ws Stap.au      S    S S  S S 
118.  33 M Ip Ws Stap.au         S   S S S 
119.  10 M Ip Ws Stap.au         S  S S S S 
120.  55 F Ip Ws NG               
121.  33 F Ip Ws Ps.ar         S  S    
122.  16 F Ip Ws NG               
123.  26 F Ip Ws NG               
124.  7 M Ip Ws NG               
125.  18 F Ip Ws Ps.ar     S    S  S    
126.  32 F Ip Ws Kleb.pn E          S    
127.  28 F Ip Ws Stap.au          S S  S S 
128.  4 F Ip Ws Stap.au  +    S    S S  R S 
129.  22 F Ip Ws Kleb.pn           S S   
130.  2 F Ip Ws NG               
131.  22 F Ip Ws NG               
132.  67 F Ip Ws Stap.au  +  S S S    S S  R S 
133.  56 F Ip Ws Kleb.pn E   S S      S    
134.  57 F Ip Ws Kleb.pn E   S       S    
135.  45 M Ip Ws E.coli E          S    
136.  25 F Ip Ws NG               
137.  42 M Ip Ws Stap.au  +   S S    S S  R S 
138.  70 M Ip Ws entero   S            
139.  24 F Ip Ws Stap.au  + S S      S S  R S 
140.  15 F Ip Ws NG               
141.  52 M Ip Ws Stap.au    S S S S S S S S S S S 
142. S 24 F Ip Ws Stap.au  +  S S S S S S S S S R S 
143. S 37 M Ip Ws NG               
144.  32 M Ip Ws Stap.au  +  S      S S  R S 
145.  25 M Ip Ws NG               
146.  35 F Ip Ws NG               
147.  51 F Ip Ws Acineto         S   S   
148.  37 M Ip Ws NG               
149.  11 M Ip Ws CONS    S  S S S S S S S   
150.  24 M Ip Ws Stap.au  +        S S  R S 
151.  42 M Ip Ws NG               
152.  24 F Ip Ws NG               
153.  25 F Ip Ws NG               
154.  11 F Ip Ws NG               
155.  14 M Ip Ws Stap.au    S    S S S S  S S 
156.  2 M Ip Ws NG               
157.  29 F Ip Ws NG               
158.  29 F Ip Ws NG               
159.  32 F Ip Ws Kleb.pn E        S  S    
160.  28 F Ip Ws Stap.au    S  S S S S S S S S S 
161. S 75 M Ip Ws Kleb.pn    S S      S    
162.  36 M Ip Ws Stap.au    S S    S S S  S S 
163.  55 F Ip Ws Kleb.pn E        S  S    
164.  20 F Ip Ws NG               
165.  25 M Ip Ws Kleb.pn E        S  S    
166.  18 F Ip Ws Kleb.pn     S      S    
167.  38 F Ip Ws Stap.au   S S S S S S S S S S S S 
168.  61 M Ip Ws Entero   S  S S         
169.  37 M Ip Ws Stap.au          S S  S S 
170.  40 M Ip Ws NG               
171.  17 M Ip Ws Stap.au  +       S S S  R S 
172.  35 F Ip Ws Stap.au          S S  S S 
173.  23 F Ip Ws Stap.au  +       S S S  R S 
174.  24 F Ip Ws Stap.au         S S   S S 
175.  9 M Ip Ws NG               
176.  16 F Ip Ws Kleb.pn    S S      S S   
177.  47 M Ip Ws NG               
178.  62 M Ip Ws NG               
179.  19 M Ip Ws Stap.au    S S     S S  S S 
180.  35 M Ip Ws Stap.au          S S  S S 
181.  4 F Ip Ws Kleb.pn    S S S S  S S S S   
182.  9 M Ip Ws Kleb.pn     S      S S   
183.  6 M Ip Ws Kleb.pn    S S      S S   
184.  32 F Ip Ws Stap.au          S S  S S 
185.  20 F Ip Ws Stap.au  + S S S S S S S S S S R S 
186. s 55 M Ip Ws Stap.au   S S S S S S S S S S S S 
187. s 55 M Ip Ws Kleb.pn         S   S   
188.  24 M Ip Ws Pseudo    S S    S  S S   
189.  40 F Ip Ws Stap.au   S S S S S S S S S S S S 
190. S 24 F Ip Ws NG               
191.  23 F Ip Ws Stap.au  +  S      S S  R S 
192.  3 M Ip Ws Stap.au    S S S S  S S S S S S 
193.  14 M Ip Ws Stap.au          S S  S S 
194.  28 M Ip Ws NG               
195.  27 F Ip Ws Stap.au  +  S      S S  R S 
196.  10 F Ip Ws Stap.au    S      S S  S S 
197.  51 M Ip Ws Kleb.pn E   S S    S  S    
198.  30 M Ip Ws CONS   S S S S S S S S S S   
199.  34 F Ip Ws NG               
200.  11 M Ip Ws NG               
201.  55 M Ip Ws NG               
202.  40 M Ip Ws Kleb.pn E    S    S  S    
203.  22 F Ip Ws Kleb.pn         S      
204.  24 F Ip Ws Kleb.pn         S      
205.  22 M Ip Ws NG               
206.  28 M Ip Ws NG               
207.  29 F Ip Ws NG               
208.  24 F Ip Ws NG               
209.  11 M Ip Ws NG               
210.  24 F Ip Ws NG               
211.  45 F Ip Ws Kleb.pn     S    S      
212.  20 F Ip Ws Stap.au  +       S S S  R S 
213.  35 M Ip Ws Ps.ar         S      
214.  9 M Ip Ws Stap.au    S       S  S S 
215.  2 M Ip Ws Stap.au    S S     S S  S S 
216.  18 F Ip Ws Ps.ar     S    S  S    
217.  9 M Ip Ws Stap.au   S  S      S  S S 
218.  3 M Ip Ws Stap.au   S      S    S S 
219.  57 F Ip Ws E.coli E   S       S    
220.  27 M Ip Ws NG               
221.  25 F Ip Ws NG               
222.  30 F Ip Ws NG               
223.  60 M Ip Ws NG               
224.  11 F Ip Ws NG               
225.  22 F Ip Ws NG               
226.  37 F Ip Ws Ps.ar    S S    S  S    
227.  28 F Ip Ws NG               
228.  47 M Ip Ws NG               
229.  36 F Ip Ws NG               
230.  11 M Ip Ws Stap.au    S S S S S S S S S S S 
231. S 58 M Ip Ws Stap.au  + S  S S     S  R S 
232.  22 M Ip Ws Ps.ar         S  S S   
233.  34 F Ip Ws Ps.ar    S     S  S S   
234.  74 M Ip Ws NG               
235.  36 M Ip Ws Stap.au  +  S S     S S  R S 
236.  22 F Ip Ws NG               
237.  21 M Ip Ws Kleb.pn         S  S S   
238.  2 M Ip Ws NG               
239.  36 M Ip Ws NG               
240.  17 M Ip Ws NG               
241.  28 F Ip Ws NG               
242.  23 F Ip Ws NG               
243.  40 M Ip Ws NG               
244.  5 F Ip Ws NG               
245.  36 M Ip Ws Kleb.pn    S S    S  S    
246.  17 M Ip Ws NG               
247.  46 F Ip Ws NG               
248.  20 M Ip Ws NG               
249.  20 F Ip Ws Entero    S S S     S    
250.  11 F Ip Ws Ps.ar         S   S   
251.  30 M Ip Ws NG               
252.  37 M Ip Ws Kleb.pn     S    S      
253.  60 F Ip Ws Stap.au  +  S S S   S S S S R S 
254.  27 F Ip Ws NG               
255.  25 M Ip Ws Ps.ar     S    S  S    
256.  70 F Ip Ws NG               
257.  40 F Ip Ws NG               
258.  34 F Ip Ws NG               
259.  26 F Ip Ws NG               
260.  56 F Ip Ws NG               
261.  23 M Ip Ws NG               
262.  18 F Ip Ws NG               
263.  60 M Ip Ws Ps.ar    S     S  S    
264.  70 F Ip Ws Entero    S S S S S S S S S   
265. S 24 M Ip Ws NG               
266.  36 M Ip Ws Ps.ar    S S    S  S    
267.  28 F Ip Ws Kleb.pn     S    S      
268.  1 F Ip Ws Stap.au          S S  S S 
269.  30 M Ip Ws NG               
270.  74 M Ip Ws Kleb.pn     S    S  S    
271.  15 F Ip Ws NG               
272.  22 F Ip Ws NG               
273.  32 M Ip Ws NG               
274.  26 F Ip Ws NG               
275.  28 M Ip Ws NG               
276.  20 F Ip Ws Kleb.pn     S    S      
277.  33 M Ip Ws Ps.ar    S S    S S S    
278.  20 M Ip Ws NG               
279.  8 F Ip Ws Ps.ar     S    S  S    
280.  9 M Ip Ws Ps.ar         S   S   
281.  23 F Ip Ws Stap.au    S S     S S S S S 
282.  25 F Ip Ws NG               
283.  35 M Ip Ws NG               
284.  60 M Ip Ws NG               
285.  18 F Ip Ws NG               
286.  58 M Ip Ws NG               
287.  26 M Ip Ws NG               
288.  42 F Ip Ws NG               
289.  36 M Ip Ws NG               
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